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The novel metal-binding tripeptide asparagine-cysteine-cysteine (NCC) is capable of 
coordinating a metal ion, and we are exploring its use in several biological applications. 
Different metals may be incorporated into this tag, and when it is placed in line with a peptide or 
protein that has the potential to be used as a targeting agent, it has the potential to facilitate the 
diagnosis, treatment, and evaluation of cancers and other diseases.  For example, platinum may 
be used as an anti-cancer therapeutic, whereas nickel generates a catalytic antioxidant.  The 
advantage of this tag is that it is extremely small, is composed of naturally occurring amino 
acids, and binds metal with unique geometry. Metal binds irreversibly at physiological pH but is 
released upon modest acidification, as occurs with endocytosis.  
In order to utilize the tripeptide as a metal-binding tag, it is important to understand the 
structure, reactivity, and stability of this novel system.  Initial studies with nickel established that 
NCC binds metal with 2N:2S geometry.  Electronic absorption, circular dichroism (CD), and 
magnetic CD (MCD) data collected for Ni-NCC are consistent with a diamagnetic NiII center 
bound in square planar geometry.  This complex acts as a mimic of the enzyme nickel 
superoxide dismutase (Ni-SOD), which catalyzes the disproportionation of superoxide to 
hydrogen peroxide and molecular oxygen.  
Changes in the CD signal of Ni-NCC indicate the optical activity of the complex changes 
over time, but mass spectrometry data show that the mass of the complex is unchanged, which 
suggests chiral rearrangement of the complex occurs.  Performing the reaction in D2O allows 
incorporation of deuterium into non-exchangeable positions, indicating chiral inversion occurs at 




chirality of the final nickel-peptide complex is DLD-NCC. Characterization of the NCC sequence 
within a longer peptide shows that the geometry of metal coordination is maintained, though the 
electronic properties of the complex are varied to a small extent due to bis-amide coordination.  
Chiral inversion does not happen in the same two positions, though initial studies suggest 
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Chapter 1:  Chemistry of nickel complexes in biological systems: 
Metalloproteins, metalloenzymes, and peptide-metal complexes 
!
Bioinorganic chemistry is a broad field that examines the role of transition metals in a 
variety of biological systems.  One major segment of this field involves studies focused on 
metalloproteins; metalloproteins utilize different transition metals for various structural and 
functional purposes.  Metalloproteins comprise one-third of all structurally characterized 
proteins, where, in the cell, their purpose is to not only sequester metal ions from undesired 
reactivity but to participate in intercellular metal trafficking.1,2 Metalloproteins also participate in 
such roles as maintaining structure, dioxygen transport, electron transfer, and specific catalytic 
purposes (metalloenzymes).3 Much diversity is observed among the structure and function of 
these metalloproteins, depending not only on the identity of the metal ion but also on how the 
metal is coordinated, nearby structural features, and the overall structure of the protein. 
 
1.1. Transition metals in biological systems 
!
The side chains of a subset of amino acid residues are involved in the coordination of 
metal ions, particularly histidine, cysteine, aspartic acid, and glutamic acid.  Ligands 
coordinating metal ions often include nitrogen, oxygen, or sulfur.  As such, the backbone of 
polypeptides can also participate in metal coordination.  The hard and soft acids and bases 
(HSAB) principle applies to metal binding to peptides and proteins; the HSAB nature of the set 
of ligands can drive specificity for coordination of certain metals.  Specifically, large, more 
polarizable (soft) ligands prefer to coordinate with larger, softer metals, while small, less 
polarizable (hard) charged metal cations prefer to coordinate with oxygen or nitrogen ligands.3 
! !
! 2!
The HSAB properties of a metal determine how it binds, but transition metals also have 
very distinctive properties based on their d-shell electron count and charge. For example, zinc, 
with a filled d shell, frequently plays a structural role in proteins, such as is the case in zinc 
finger proteins and superoxide dismutase.  In these cases, zinc does not participate in a catalytic 
reaction but simply plays a structural role; however, in other zinc proteins, such as carbonic 
anhydrase, carboxypeptidase, zinc can act as a Lewis acid to promote catalysis. Other first row 
transition metals, such as iron, nickel, and copper, lack a full d shell and therefore can move 
between different oxidation states to facilitate electron transfer reactions and promote catalysis.  
The research in this dissertation pertains to nickel chemistry and, as such, this chapter will focus 
on nickel-containing proteins.   
 
1.2 Coordination of nickel in proteins: basic principles 
!
Nickel is a redox-active metal that is found in various metalloproteins and 
metalloenzymes.  Divalent nickel cations are borderline hard-soft acids (metals) and can 
therefore be coordinated by many of the common ligating residues.  It is often bound to sulfur 
ligands from cysteine or occasionally methionine, nitrogen ligands from the peptide backbone, 
histidine residues, and/or oxygen ligands from aspartic or glutamic acid.3 The identity of the 
ligands determine the functionality of the nickel complex; while some ligands bind more loosely 
and are used for metal transport, others bind tightly, almost irreversibly, in order to promote 
catalysis.  The coordination number, geometry, bond lengths, and type(s) of ligating atoms about 
the metal determines how easily it is released, as is the case with nickel trafficking proteins.1 
The differences in the structure of nickel binding sites impacts their function.4 
Specifically, the octahedral, lower affinity sites can more easily release metal; high spin 
! !
! 3!
nickel(II) centers are more likely to exchange their ligands via a dissociative mechanism, while 
ligand exchange in planar complexes utilizes an associative one that depends on the 
nucleophilicity of the incoming ligand. For this reason, it is more difficult to exchange the four 
coordinate, planar ligands, and they are less likely to release nickel.  The octahedral, six 
coordination NiII sites can release metal when nickel concentrations are lower.4 This selectivity 
of metal release is useful for these proteins that are involved in metalloregulation.  Additionally, 
it can be concluded that complexes with cysteinyl ligands have higher affinity for nickel than 
those that do not.  Many metallochaperones, where nickel binding needs to be reversible, 
coordinate the metal through the lower-affinity nitrogen ligands,5 though this trend is not 
universal. Those proteins that utilize cysteine ligands often require a binding event, such as ATP 
hydrolysis or complexation with another nickel-binding protein, to release their metal.6,7 Finally, 
it has been suggested that thiolate ligation is necessary for enzymatic activity, as this ligation 
helps tune the redox potential to one appropriate for catalysis;5,8 however, the simple presence of 
a thiolate ligand is not enough to designate a protein as a catalytic enzyme. Several 
metallochaperones that have up to three sulfur ligands have been reported to lack catalytic 
activity.  
Among catalytic nickel enzymes, the redox potential of transition metal complexes is 
tuned by its ligands, where the characteristics of the ligands impact the redox potential of the 
metal and its binding mode.3 Nickel is commonly found in the +2 and +3 redox states, though it 
can also cycle through the +1 state, making it versatile in both its coordination geometry and 
reactivity.9 Nickel(II) is a d8 metal ion, making it energetically favorably to utilize a mononuclear 
square planar or square pyramidal geometry; however, it is not uncommon for nickel to be 




1.3. Catalysis in nickel enzymes 
!
Nickel cofactors in enzymes vary in their structure and function; nickel can coordinate in 
different geometries and has a wide potential for redox chemistry, as +1, +2, +3 states are all 
possible, and it can catalyze reactions over a range of 1.5 V. With this variety of reactivities, the 
coordination environment about the metal center plays a large role in defining the reactivity of 
the enzyme.  In known nickel enzymes, nickel coordination may be mononuclear, part of a 
pyrrole cofactor, or part of a metal cluster.9 
The ability of enzymes to promote catalytic processes is often driven by the primary 
coordination sphere and nearby structural components.  The secondary environment around the 
metal center, however, often promotes the more subtle differences in redox potential that also 
drive differences in reactivity.  Additionally, this proximal structure often drives substrate 
binding.  For this reason, the structure/function relationship of nickel enzymes is not only 
dependent on the direct metal ligation but also on the nearby substrate binding cavities.  These 
secondary structural effects are not present in peptide-metal complexes, and therefore, the use of 
peptide mimics permits direct study of first sphere effects, including differences in coordinating 
residues and metal geometry. 
 
1.4. Metal abstraction peptide (MAP) 
!
 The metal abstraction peptide (MAP) is a tripeptide with the sequence asparagine-
cysteine-cysteine (NCC) that is capable of coordinating a variety of metal ions, including nickel.  
Upon incubation with immobilized metal affinity chromatography (IMAC) resin, metal is 
transferred to the peptide to generate a unique metal-tripeptide complex. Initial studies on the 
! !
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tripeptide complex performed with nickel revealed that NCC binds metal with a 2N:2S geometry 
(Chapter 2).  Electronic absorption, circular dichroism, and magnetic CD (MCD) data collected 
for Ni-NCC are consistent with a diamagnetic NiII center bound in square planar geometry. The 
metal complex formed is extraordinarily tightly bound such that extreme temperature, saturating 
amounts of denaturants and enormous excesses of the chelator EDTA fail to disrupt binding.  
The metal is incorporated more rapidly with increasing pH and is released specifically by 
acidification. These properties are highly compatible with use of the peptide as a tag for targeted 
delivery and controlled release in biological systems. This sequence can be placed in line with a 
protein or peptide that has the potential to be used as a targeting agent. When paired with an 
appropriate metal or isotope, the tag can be used to facilitate the diagnosis, treatment, and 
evaluation of cancers and other diseases.  While platinum may be used as an anti-cancer 
therapeutic, nickel generates a catalytic antioxidant complex.  In order to utilize the tripeptide as 
a metal-binding tag, however, it is important to understand the structure, reactivity, and stability 
of the novel system, which is the focus of this dissertation. 
 
1.4.1. MAP has superoxide dismutase activity 
!
Ni-NCC acts as a mimic of the enzyme nickel superoxide dismutase (Ni-SOD), which 
catalyzes the disproportionation of superoxide to hydrogen peroxide and molecular oxygen 
(Chapter 2).  While peptide mimics of Ni-SOD have been explored in the past,10,11,12 the MAP 
sequence differs in that it is not derived from the sequence of the parent enzyme yet acts as a 
functional mimic of the enzyme.  The MAP complex and Ni-SOD both have 2N:2S 
coordination; while Ni-NCC is much less efficient than Ni-SOD, it shows activity and maintains 
a redox potential in the appropriate range (vide infra) to disproportionate superoxide.  It has 
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exceptional stability, resisting degradation during long-term storage, elevated temperature, and 
exposure to light and oxygen, making it compatible for use as a therapeutic agent. 
 
1.4.2. MAP undergoes nickel dependent, site-specific chiral inversion 
!
Unlike Ni-SOD and unlike any metal-polypeptide complex known, Ni-NCC undergoes 
rapid chiral rearrangement under ambient conditions (Chapter 3). CD aging profiles, H/D 
exchange mass spectrometry, and studies on peptides synthesized to contain D amino acids 
indicate chiral inversion occurs at the alpha carbon atoms at the first and third position within the 
tripeptide. To our knowledge, this is the first example of site-specific chiral inversion of amino 
acids within polypeptides that depends on metal binding.   
 
1.4.3. NCC embedded in longer sequences 
 The effect of including NCC within longer peptides is conversion of the N-terminal 
amine to an amide, which alters the first coordinating ligand to the metal center.  The 
incorporation remains rapid, nickel binding results in the same structure, and SOD activity is 
observed for all NCC-containing peptides (Chapter 4).  The redox potential is altered somewhat, 
as expected by the nitrogen ligand being an amine in a tripeptide and an amide in the case of a 
longer sequence, but both facilitate superoxide disproportionation.  While the chiral 
transformation of the tripeptide Ni-NCC can be detected by CD, no change is observed for the 
pentapeptide, suggesting either a chiral inversion is not necessary for SOD activity of the bis-
amide form or inversion occurs even more quickly and concomitant with metal incorporation.  
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Studies to examine the differences between the tripeptide and the sequence embedded in longer 
peptides suggest chiral inversion may occur, but in a different position than in the tripeptide.      
 
1.5. Catalytic, mononuclear nickel centers:  Nickel superoxide dismutase (Ni-SOD) 
!
The Ni-NCC complex acts as a structural and functional mimic of Ni-SOD. Superoxide 
dismutases catalyze the disproportionation of the toxic anion superoxide to molecular oxygen 
and hydrogen peroxide. Ni-SOD is the most recently discovered superoxide dismutase.13-15 This 
enzyme contains a mononuclear Ni site, specifically where the metal is bound in a 2N:2S, square 
planar nickel(II) geometry, utilizing two nonadjacent cysteine side chains, a backbone amide 
nitrogen, and the N-terminal amine as ligands.  In isolated samples of oxidized Ni-SOD, a fifth, 
axial histidine ligand is coordinated to the nickel(III) ion, and oxidation of the metal center to 
nickel(III) during catalysis may be concomitant with coordination of this axial ligand.16 The 

















Figure 1.1.  Active site of Ni-SOD, showing the directly coordinating metal ligands (H1, C2, C6) and nearby, 
catalytically important residues (H1 side chain, Y9, Y62, and E11 (not shown)).  Reproduced with permission from 
Herbst, R. et al.19 
! !
! 8!
The presence of two cysteine ligands helps maintain the NiII/NiIII redox couple that is 
necessary to catalyze the disproportionation reaction, and without both cysteine residues, 
catalysis is not possible because nickel coordination becomes octahedral and binding affinity is 
decreased.20,21 Ni-SOD has to maintain a redox potential that is somewhere between that 
necessary for each of the half reactions of superoxide disproportionation (-160 mV vs. NHE for 
the O2/O2
·- redox couple and 870 mV vs. NHE for the O2
2-/O2
·- redox couple).22,23 During catalysis 
of Ni-SOD, an axial histidine ligand is critical, stabilizing the nickel(III) oxidized state and 
tuning the nickel redox potential for superoxide disproportionation,18,19 where the NiII/NiIII redox 
potential is higher for a four-coordinate nickel center versus a five-coordinate nickel center.19 
Without the axial histidine, the nickel is mostly reduced, and because the reduced form promotes 
one of the superoxide half-reactions and the oxidized form catalyzes the other, an approximately 
100-fold reduction in the rate of disproportionation is observed.16 
While the active site itself is tuned for superoxide disproportionation, outside of the 
primary coordination sphere, other factors influence the reactivity of Ni-SOD. Ni-SOD is a 
homohexamer, and interaction between the subunits appears to promote enzymatic activity.17-19 
Interestingly, the fully oxidized form of the enzyme maintains 50:50 NiII/NiIII, supporting this 
cooperativity and communication between adjacent monomers.19 Mutagenesis of residues His1, 
Asp3, Glu17, Arg39 and Arg47 impacted or completely prevented the reactivity of the protein.17 
Glu17 likely interacts with the axial histidine ligand and impacts reactivity.17 Some of these 
residues are important for stabilizing the nickel-hook motif that allows metal binding,18 while 
others are involved in stabilizing substrate binding during catalysis and still others act as proton 
donors during catalysis.19 For example, if Pro5 is trans instead of cis, Cys6 is misaligned for 
metal binding.18 Tyr9 is thought to be important in gating access to the nickel ion, preventing 
other, undesired anions from entering. Without gating, other anions would repulsively prevent 
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anionic superoxide from entering, impacting activity of the enzyme.17,19,24 Additionally, 
mutagenesis of Tyr9 leads to differences in the Ni-S bond, although mutation of Tyr9 did not 
change the redox potential of the metal.19 Asp3 impacts the position of Tyr9, also affecting 
reactivity.19 The primary coordination of the metal is what drives the redox potential, directly 
impacting reactivity, yet, interestingly, larger structural differences and the secondary 
coordination sphere impact reactivity without changing the redox potential.   
 
1.6. Models of metalloenzyme active sites: peptide-based mimics of Ni-SOD 
!
Studies on metalloenzymes can be complex. While identifying residues involved in the 
metal binding can be accomplished using site directed mutagenesis and structural studies, 
probing the geometry and redox states of the metal throughout a catalytic process can be more 
difficult, especially due to synergistic effects that result from the unique environment within a 
folded protein.  In addition to the impact of primary ligands to the metal center on both structure 
and reactivity, nearby residues can alter the reduction potential of the metal, residues direct 
substrate access and provide pockets for substrate binding, and the overall protein fold can direct 
access of the substrate or co-substrates to the active site. The secondary coordination sphere and 
other, more distant structural features can also impact the reactivity of the complex.  
Understanding this type of convoluted system can be difficult, especially without structural data.  
To mitigate this problem, the use of either truncated peptide complexes or synthetic compounds 
has aided in the understanding of the immediate reactivity of these complex systems.  While the 
activity of enzymes as a whole is impacted by secondary coordination sphere and overall protein 
fold, the use of synthetic complexes and peptide mimics provides insight into the immediate 
coordination and reactivity of the enzymes.  The literature is rich in nickel complexes, both 
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synthetic and peptide-based, that mimic the activity of various nickel enzymes.  The focus of this 
work is on peptide complexes that accommodate nickel in square planar and square pyramidal 
geometry, especially those with nitrogen and sulfur coordination.  The primary examples of such 
coordination and geometry typically mimic Ni-SOD and have been examined to better 
understand inner-sphere effects on this enzyme’s function.   
 
1.6.1. Peptide maquettes of Ni-SOD 
 Ni-SOD lends itself nicely to peptide mimic work, as all of the ligands required for metal 
binding are present in the N-terminus of the enzyme, which is referred to as the metal hook.17,18 
Only a few known synthetic mimics of Ni-SOD exhibit a midpoint potential in the range 
appropriate for SOD activity;25,26 alternatively, peptide mimics of Ni-SOD derived from the 
parent enzyme, known as peptide maquettes, have been able to successfully reproduce the 
activity of the enzyme, albeit with less efficiency.  Designing various, systematic differences into 
these maquettes has proved useful in the understanding of how the enzyme works as a whole. 
The first maquette of Ni-SOD was composed of the 12 N-terminal residues 
(HCDLPCGVYDPA) from the Ni-SOD of Streptomyces coelicolor and is referred to as 
[Ni(SOD)M1].10 This maquette binds nickel in a 1:1 ratio, as does Ni-SOD, and while only the NiII 
form can be isolated, this maquette exhibits superoxide dismutase activity and has an appropriate 
redox potential for superoxide dismutation (Table 1.1).10 In addition to the direct coordination 
sphere, this maquette includes both the His1 and Tyr9 residues that are known to affect activity 
of the intact Ni-SOD enzyme. Nonetheless, this maquette’s activity is greatly diminished with 




Table 1.1.  Comparison of peptide maquettes to Ni-SOD. 
 
  
Ni-SOD is one of few proteins that coordinates nickel using its N-terminus.  This allows 
the 2N:2S coordination to utilize one amine ligand and one amide ligand, where the amine is 
provided by the N-terminal end of the enzyme.  For this reason, it was of interest to force the 
amine to become an amide to determine how this would impact the reactivity of the peptide 
maquette.  [NiII(SODM1-Ac)] maintains the same sequence as the first maquette, but the N-
terminus is acetylated, which provides bis-amide nickel coordination. The bis-amide form of the 
peptide displays a lower redox potential (0.49 vs 0.70) yet has catalytic activity that is two orders 
of magnitude lower than the mixed amine/amide maquette. This acetylated maquette maintains 
the same sequence as the original 12mer and therefore retains His1 and Tyr9, which are relevant 
for activity.  The comparison shows that the difference between amine/amide and bis-amide 
coordination alters both the redox potential and activity.  Interestingly, the lower activity of the 










Ni-SOD Cis Amine/amide 0.09 V 19,27 4 x 10-8  M 
[NiII(SOD)M1] Cis Amine/amide 0.70 V 10,11 2.1 x 10-7 M 
[NiII(SODM1-Ac)] Cis Bis amide 0.49 V 11 3 x 10-5  M 
[NiII(SOD)M2] Cis Amine/amide 0.52 V 12 1 x 10-6 M 
[NiII(SOD)M2-(D)] Cis Amine/amide 0.48 V 12 5 x 10-6 M 
[NiII(SODM2-(A)] Cis Amine/amide 0.67 V 12 3 x 10-5 M 
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be higher in the bis-amide than the mixed amine/amide maquette because the potential is closer 
to that of the native enzyme.  Therefore, other properties of the metallopeptide complex may 
modulate reactivity, such as the increased anionic character of the bis-amide shell being more 
repulsive to approach of the anionic superoxide substrate, and investigation into these factors 
continues.11 
An axial histidine ligand is involved in the catalysis of Ni-SOD.16 With the maquettes, the 
peak separation in electrochemical studies is wide enough to suggest a change in coordination 
environment upon nickel oxidation, supporting involvement of a histidine ligand throughout 
catalysis.11 To selectively probe the importance of this axial ligand and to help determine if the 
axial histidine remains coordinated throughout catalysis, maquettes with alternative N-terminal 
residues were synthesized and examined.  Here, only seven residues were used in the maquette to 
represent what is minimally necessary for metal binding (XCDLPCG, where X is histidine, 
aspartic acid, or alanine) and to look specifically at the impact of the histidine on reactivity.  In 
Table 1.1, [NiII(SOD)M2] is the 7mer with the native sequence, but [NiII(SOD)M2-(D)] and 
[NiII(SOD)M2-(A)] are the aspartic acid and alanine substituted sequences.  This study suggests 
that once the histidine is axially bound, it remains coordinated and catalysis follows an outer 
sphere mechanism.  Regardless, the substitution of the histidine with alanine or aspartic acid 
reduces its efficiency by 100 fold and alters its redox potential.  These results show that the axial 
histidine may play several roles in the mechanism, including structural rearrangement, making 
the redox potential more negative, and ensuring nickel-based oxidation rather than thiolate 
oxidation.12 One study suggested that a proline (Pro5) isomerization to the trans form was the 
reason for the reduced activity in biomimics of Ni-SOD, acting as the fifth ligand in the absence 
of histidine,24 but more recent studies on sequences where the cis-conformation was forced did 
not have improved activity over the previous mimics.28 
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Cyanide can be used to mimic substrate binding to the peptide sequence; reaction of 
cyanide with a 9mer maquette showed that this anion can bind to the metal, as demonstrated by 
IR.  This suggests again the possibility of an inner sphere mechanism, where the substrate binds 
in an axial position to oxidize the enzyme, and histidine displaces the oxidized, hydrogen 
peroxide product.29 While the discussion of an inner sphere or outer sphere mechanism is still 
underway, the use of peptide maquettes that maintain similar primary coordination and mimic 
the reactivity of the whole enzyme may inform this debate.23,24 
 
1.7. Catalytic nickel enzymes 
 
Comparison of Ni-SOD to other nickel-containing enzymes promotes fundamental 
understanding of the factors that drive nickel-based catalysis. A recent review describes six 
major known nickel enzymes,9 including urease, hydrogenase, carbon monoxide dehydrogenase, 
methyl coenzyme M reductase, acetyl-coenzyme A synthase, and the more recently discovered 
nickel superoxide dismutase,9,30,31 as well as two lesser studied enzymes, glyoxalase I and 
acireductone dioxygenase. These two are less commonly recognized as nickel enzymes because 
they often bind other metals in the same active site.32,33 The major nickel enzymes employ very 
different nickel coordination environments, including a dinuclear Ni-Fe complex, a dinuclear Ni-
Ni complex, nickel in a tetrapyrrole complex, an iron sulfur cluster also containing nickel,31 and 
a mononuclear nickel center (Table 1.2).  The context of nickel is highly varied, promoting 





Table 1.2. Brief descriptive summary of major Ni-containing enzymes by classification. Non-redox active enzymes 
are shaded green, iron-sulfur cluster containing enzymes are shaded blue, and enzymes with mononuclear nickel 
sites are shaded pink.  Nim indicates the coordinating nitrogen is from an imidazole. 
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1.7.1. Catalytic nickel centers with no redox activity 
!
 The enzymes glyoxalase I,9,32 acireductone dioxygenase"9,33 and urease9,34,35 all have 
mononuclear or dinuclear nickel centers, but in these particular enzymes, the nickel remains in 
the nickel(II) redox state throughout catalysis.   !
1.7.1.1. Glyoxalase I. Glyoxalase I is part of a series of enzymatic reactions that catalyze 
the conversion of methylglyoxal to lactate.  Specifically, glyoxalase I utilizes an octahedral 
nickel ion that remains in the +2 redox state throughout an isomerization reaction.  Three 
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histidine residues, one glutamic acid residue, and two water molecules coordinate the metal.  The 
metal ion acts as a Lewis acid; one of the water ligands is displaced upon substrate binding, 
allowing the coordinated glutamate to abstract a proton from the substrate before the substrate is 
reprotonated to generate an S-D-lactoylglutathione, which continues to be processed in reactions 
catalyzed by other enzymes.9,32 Interestingly, while the eukaroytic forms of this enzyme utilize 
zinc in their active site, the E. coli form is only fully active when bound to nickel and is inactive 
with zinc.  Studies suggest the coordination of the metal, rather than the properties of the metal 
itself, drive the differences in reactivity.32 
1.7.1.2. Acireductone dioxygenase. Acireductone dioxygenase is another enzyme that can 
bind different metals with different geometries to promote alternate reactivities. When nickel is 
bound, the enzyme cleaves acireductone into formate, carbon monoxide, and 
methylthiopropionate.33 Here, nickel is high spin NiII and is bound in an octahedral geometry 
with three histidine ligands, one aspartic acid ligand, and two water molecules.  Like in 
glyoxalase I, nickel remains in the +2 redox state through catalysis, acting as a Lewis acid.  In 
this reaction, the acireductone substrate displaces a water molecule, where oxygen then reacts 
with the substrate, but oxygen itself does not interact directly with the metal.9,33 Interestingly, this 
enzyme can also utilize iron in its active site, breaking acireductone into formate and 
methylthiobutyrate.  The metal-different isoforms have significant structural differences, which 
therefore changes the function of the enzyme.33 
1.7.1.3. Urease. Urease breaks down urea into ammonia and carbamic acid, which then 
hydrolyzes into carbon dioxide.34-36 The crystal structure of urease from Klebsiella aerogenes 
revealed a binuclear nickel center in each active site.37,38 The nickel ions are 3.5 Å apart; both 
utilize nitrogen and oxygen ligands and a bridging, bidentate carboxylate ligand from a 
carbamylated lysine, which is critical for appropriate metal binding.  One of the nickel ions is 
! !
! 16!
held in a square pyramidal environment, where two histidines, one water molecule, a bridging 
lysine carbamate, and one bridging water/hydroxyl molecule participate in its coordination 
(2N:3O coordination).  The other nickel, along with the shared bridging carbamylated lysine and 
bridging water, has an additional water ligand, two histidine residues, and one aspartic acid 
residue (2N:4O coordination).9,37 Once again, in urease, the nickel ions remain in the +2 redox 
state throughout catalysis; the metal simply acts as a Lewis acid.  The differences in the 
coordination of the two nickel ions drive their participation in the enzymatic activity.35 The urea 
bridges the two nickel ions; the carbonyl oxygen binds to the first nickel ion, while one amine 
group coordinates to the other nickel ion and the second amine group interacts with hydrogen 
bond acceptors in the active site pocket.  Binding of the carbonyl to the first nickel ion polarizes 
the substrate, while the second nickel increases the nucleophilicity of a bound water or hydroxide 
for its attack on the carbonyl group of the urea.  This attack forms ammonia and carbamate; 
water binds and displaces the bound ammonia and carbamate for further catalysis, and the 
carbamate spontaneously hydrolyzes to bicarbonate and another ammonia molecule. 9,34,35 
 
1.7.2. Redox active nickel enzymes with additional cofactors 
 
 Other nickel enzymes undergo redox activity throughout their catalytic processes.  In 
these enzymes, nickel is coordinated either in metal cluster cofactors or by complex nitrogen 
ligated tetrapyrrole systems that bind the nickel and are tightly coordinated to the enzyme. 
1.7.2.1. Carbon monoxide dehyrodgenase/ Acetyl-Coenzyme A synthase. Carbon 
monoxide dehydrogenase (CODH) catalyzes the reversible oxidation of CO to CO2.
9,39,40 CODH 
is sometimes found as a monofunctional enzyme, but it is often tightly bound to the enzyme 
acetyl-coenzyme A synthase (ACS).9,31,40ACS catalyzes the synthesis of acetyl coenzyme A from 
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CO (often generated by CODH), coenzyme A, and a methyl group of methylated corrinoid iron-
sulfur protein (CoFeSP).9,40 The bifunctional, coordinated form of these two enzymes, 
CODH/ACS, is an !2"2 heterotetramer (CODH, containing the C cluster, is the " subunit, and 
ACS, containing the A cluster, is the ! subunit) that catalyzes two different reactions of carbon 
monoxide.31,41 In some cases, the CO that is generated by CODH acts as one of the substrates for 
the acetyl-coenzyme A synthesis, as CO is transported through a tunnel from the active site of 
CODH to that of ACS; the enzyme switches from an open to a closed conformation throughout 
catalysis, delivering CO at a specific time during the reaction.39,40,42 
CODH catalyzes the reversible interconversion between CO and CO2.
9,39,40 Structures of 
the CODH subunit from Rhodospirillum rubrum43 and Carboxydothermus hydrogenformans44 
have been solved to reveal [Ni1-Fe4-S4] cluster for the former and [Ni1-Fe4-S5] for the latter.  In 
the C. hydrogenformans structure, the nickel is ligated in 4S geometry with three labile sulfurs 
from the iron-sulfur cluster and a fourth sulfur ligand from a cysteine residue.  Three of the iron 
atoms are coordinated via cysteine ligands and sulfurs from the iron sulfur cluster, but one iron is 
coordinated with a histidine residue.31,44 In the structure from R. rubrum, the nickel is part of the 
cluster, but the fourth iron is mononuclear and not part of the cluster.43 The nickel ion has been 
described as a nickel(II) bound in 4S, square planar geometry with the substrate CO binding in 
the axial position,42,45 though more recent crystallographic studies on an isoform from Morella 
thermoacetica argue that no bridging sulfur ligand is present and it does not participate in 
catalysis (though it may play a pre-catalytic stabilizing role), so the catalytic cluster of CODH 
should be described as a [Ni-Fe4-S4] cluster (Figure 1.2).
46 In this case, nickel is initially bound 
with 3S coordination, but during catalysis, the fourth site is filled to complete the four-
coordinate, square planar geometry.46,47 Catalysis begins with CO binding to the nickel in the 
fourth position of a square planar arrangement. The iron-bound hydroxide then attacks the 
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nickel-bound CO to form a bound carboxylate that bridges both metal ions. A nearby histidine 
acts as a catalytic base and deprotonates the bound carboxylic acid group.  CO2 is released, 
leaving a potential Ni“0” center; these two electrons are transferred first to the C cluster internally 
from the metal center to bring nickel back to the NiII state before being transferred on to other 







Figure 1.2. Active site of CODH, showing the [Ni-Fe4-S4] coordination.   
Reproduced with permission from Kung, Y. et al.46 
 
ACS catalyzes the synthesis of acetyl coenzyme A from CO (often generated by CODH), 
coenzyme A, and a methyl group of methylated corrinoid iron-sulfur protein (CoFeSP).9,40 The 
crystal structure of CODH/ACS from Moorella thermoacetica has recently been solved by two 
different groups.42,48 An iron-sulfur cluster with nickel comprises the catalytic metallocenter of 
the enzyme, called the A cluster, specifically a [Fe4-S4] cluster adjacent to a binuclear nickel-
metal cluster, where different metals, including iron, copper, and zinc have been postulated to be 
in the second position of the binuclear cluster.9,42,48 It is likely that only the bi-nickel form is 
active.42 This site is coordinated with cysteine ligands, where the four iron atoms are coordinated 
to cysteine residues, as well as the proximal nickel. The proximal nickel maintains 4S 
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coordination using one sulfur ligand from the cluster, one cysteinyl side chain, and two cysteinyl 
side chains which bridge to another, distal nickel.9 The bridging cysteine between the [Fe4-S4] 
and the proximal nickel is important for communication between the cofactors.49 The distal 
nickel is bound in a cis-2N:2S geometry by Cys-Gly-Cys sequence from the protein, using the 
two sulfur side chains and two backbone nitrogens for metal coordination.50 The proximal nickel 
ion is the active species, where the 2N:2S, bis-amide coordinated distal nickel remains as a 
bystander during catalysis.  The proximal nickel can likely stabilize two different redox states; 
the resting state of the enzyme maintains a NiII center, but in the presence of substrates, 
methylated CoFeSP and CO, the active nickel moves to either a NiI or potentially a Ni0 state.51 
The presence of the adjacent iron sulfur cluster and the distal nickel ion may allow the proximal 
nickel to reach this highly reduced state by neutralizing its cysteine ligands.42,52 Studies on the 
mechanism are still underway to probe the more likely of the nickel states.53 While early studies 
demonstrated that the CO and CH3 groups bind before CoA enters, it later became evident that 
the order of substrate binding drives the different possibilities for the nickel redox states, where 
if the methyl group binds first, a NiII/Ni0 redox couple (diamagnetic cycle) can be used, whereas 
if the CO group binds first, NiII/NiI is used (paramagnetic cycle).54 It is now thought that 
methylation occurs before CO binds, allowing control over CO binding, yet preventing formation 
of a Ni0 species that could be inactive.  ACS changes from an open to a closed conformation 
throughout catalysis.42,48,55 This conformational change allows the order of substrate binding to be 
appropriate, where after methylation, the smaller CO substrate binds.  This conformational 
change closes a tunnel, keeping CO bound and also allowing the larger CoA substrate to enter. 
More specifically, in this proposed mechanism, the methyl group binds in the fourth planar 
position to complete the planar coordination of Ni, followed by CO binding in the axial position, 
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before CO inserts into the Ni-CH3 bond to generate the acetyl group.  This acetyl group is then 







Figure 1.3. Active site of acetyl coenzyme A, showing the iron-sulfur cluster, the active proximal nickel (NiP), and 
the distal nickel (Nid).  Reproduced with permission from Ragsdale, S.W.
9 
 
1.7.2.2. Hydrogenase. [Ni-Fe] hydrogenases catalyze the reversible reduction of protons 
to form hydrogen gas.9 The enzymes are heterodimers; the smaller subunit contains one or more 
iron-sulfur clusters, but the larger subunit contains an active site with a nickel ion and an iron 
ion, where the metal ions are connected by bridging thiolate ligands.9,38 Hydrogenases have two 
conserved CXXC motifs that are involved in metal binding,56 where the nickel ion is coordinated 
by four cysteine ligands (Figure 1.4).57 Iron is bound by the two bridging cysteine ligands, as 
well as CO and two CN groups.9 A hydrophobic channel is involved in hydrogen gas transport 
through the enzyme, ending at the nickel site.58,59 In the case of H2 oxidation, an activation step is 
necessary; the enzyme must sit with H2 for a period of time before heterolytic H-H bond 
cleavage occurs, resulting in a bridging metal hydride and a proton binding to sulfur in the active 
site. The autocatalytic mechanism begins with proton coupled electron transfer (PCET) to an 
active site base that results in a nickel(III) center.  From here, hydride transfer to the attached 
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cysteinyl sulfur generates a nickel(I) center. Oxidative addition of H2 to the nickel center allows 
heterolytic cleavage, where one hydrogen ends up as a bridging hydride and the other as a proton 
on the adjacent cysteine residue.  In total, the enzyme undergoes three PCET events to regenerate 







Figure 1.4. Active site of Ni-Fe hydrogenase.  Reproduced with permission from Ragsdale, S.W.9 
 
1.7.2.3. Methyl coenzyme M reductase. Methyl-coenzyme M reductase (MCR) is 
involved in methane formation in archea.60-62 It catalyzes the reduction of methyl-coenzyme M to 
methane and a disulfide bound form of coenzyme M (CoM) and coenzyme B (CoB).  One of the 
substrates, methyl-coenzyme B, binds and creates a channel in which methyl coenzyme M can 
enter and approach the active site.  Methyl coenzyme M interacts with several residues to 
appropriately align itself in a binding pocket above the catalytic metal cofactor, including 
tyrosine, phenylalanine, histidine, and arginine.  MCR contains a tightly bound coenzyme F430 
nickel catalytic center, which is a nickel hydrocorphin where nickel is coordinated in an 
octahedral geometry.  Four nitrogen atoms from the pyrrole ring provide the planar ligands, 
while one axial ligand is provided by the side-chain oxygen of glutamine and the other axial 
position is occupied by the substrate methyl CoM (Figure 1.5).63 Many of the residues forming 
the active site pocket are chemically modified; these modifications are likely required for activity 
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of the enzyme, even among phylogenetically different organisms that utilize this type of 
enzyme.64 The F430 cofactor in MCR cycles from NiI to NiIII, where catalysis can only be 
initiated by the NiI resting state of the enzyme.9,63 Different mechanisms that describe binding to 
the free axial position during catalysis and hydrogen transfer to the methyl group have been 
proposed.63,65 In the first, it is suggested that the methyl group on methyl CoM nucleophilically 
reacts with NiI to generate methyl-NiIII and coenzyme M.  The methyl-NiIII becomes methyl-NiII 
with a thiyl radical, where methyl-NiII then reacts with a proton to produce methane and NiII.63-65 
Alternatively, the methyl-thioether bond on CoM is homolyzed, generating a methyl radical that 
then reacts with CoB. This produces methane and a CoB thiyl radical that is available for 
reaction with the CoM radical to form a disulfide bond.65 It has been proposed that MCR may 
also be involved in the anaerobic oxidation of methane to carbon dioxide.65-67 Although studies 
on this enzyme are still underway, more recent studies using analogues of CoB suggest that 
methyl-CoM is the key coenzyme triggering the necessary conformational changes in MCR and 
therefore catalysis.68 The highly reduced nickel(I) species required for activity is achieved only 
by the presence of the F430 cofactor; this tetrapyrrole cofactor allows the unique nickel behavior 









Figure 1.5. Active site of methyl coenzyme M reductase, showing the F430 tetrapyrrole cofactor.  




1.7.3. Comparison of nickel enzymes 
!
Of the eight nickel enzymes described above, each has a unique active site, where nickel 
performs a wide variety of chemistry.  Three of the nickel enzymes bind with strictly nitrogen 
and oxygen ligands, but these three enzymes (glyoxalase I, acireductone dioxygenase, and 
urease) utilize nickel simply as a Lewis acid where the metal remains in the NiII state throughout 
catalysis.  Methyl coenzyme M reductase is unique in that it cycles between nickel(I) and 
nickel(III) throughout its catalytic mechanism, but it is coordinated with four nitrogen ligands 
and an axial glutamine ligand; however, the source of the nitrogen ligands is an F430 cofactor, 
which provides very different electronic properties than 4N coordination from all protein-based 
ligands.   
The other four Ni-enzymes are redox active and cycle between various nickel states, from 
a possible Ni0 state all the way to NiIII. For each of these four enzymes, sulfur ligation is critical 
for tuning the redox potential into a biologically relevant range.10,11 Three of the remaining 
enzymes contain iron-sulfur cofactors (hydrogenase, CODH, ACS).  Each of these enzymes 
reacts with a gaseous substrate and has a long hydrophobic tunnel leading to the catalytic nickel 
ion. In each of these enzymes, the catalytic nickel has two available cis coordination sites to 
interact with substrate and all of the coordinated ligands are sulfur based.  Additionally, all three 
of these proteins utilize a catalytic mechanism that involves more than a one-electron process.69 
Ni-SOD is a Ni-enzyme that contains a mononuclear metal center with no other source of 
potential electrons to facilitate catalysis. Likely for this reason, it only cycles between nickel(II) 
and nickel(III) during its catalytic mechanism.  All of its ligands are protein based, maintaining a 
2N:2S coordination, or 3N:2S in the oxidized form.  This mixture of nitrogen and sulfur ligands 
differs from the coordination of the other nickel enzymes, which utilize either 4S or 4-6N/O 
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ligation.  Perhaps these differences explain why Ni-SOD is capable of catalyzing a one-electron 
process; the ligands to a metal tune its reduction potential, in this case impacting the reactivity of 
Ni-SOD.    
Monodentate ligands can also interact with the nickel(III) species that forms, particularly 
imidazole; even in simple peptide complexes, solvent (water) can act as an axial, transient ligand 
and impact the potential of the NiII/NiIII redox couple.70,71 This is the case in Ni-SOD, where an 
axial histidine ligand coordinates to NiIII during catalysis. This helps tune the redox potential for 
superoxide dismutase activity; Ni-SOD catalyzes a disproportionation reaction, and its redox 
potential must be between those of the two different half reactions.  The addition of the axial 
histidine ligand makes the potential more negative and appropriate to catalyze both reactions.     
 
1.8. Peptide-nickel complexes 
!
 Many of the nickel binding proteins described above have nickel-peptide analogues, the 
examination of which has greatly aided in understanding the chemistry and coordination of the 
metal binding sites in these proteins.10,72 A review of key nickel-binding reveals common themes 
important to understanding fundamental properties of nickel-based chemistry. Unrelated peptides 
to the aforementioned enzymes have also been shown to perform chemistry and are described 






1.8.1. Nickel-binding by Cys-X-Cys motif 
!
Cys-X-Cys is a common metal binding motif found in proteins.  Cys-Gly-Cys is found in 
the enzyme ACS, and this sequence has been examined as an isolated peptide to characterize its 
nickel binding properties. Studies on the peptides CGC and CPCP, used in their acetylated and 
native forms, have shown that CXC peptides typically dimerize around nickel with 4S ligation. 
When glycine is present in the X position, this peptide is able to utilize amide coordination and 
form a monomeric 2N:2S complex with nickel. While acetylated CPCP forms dimeric 
complexes using all sulfur ligands, the amine groups on the free CPCP formed 2N:2S complexes, 
but still used two peptides per metal ion.73 Comparison of this sequence to sequences with 
adjacent cysteines implies that an interceding glycine is small enough to allow the side chains of 
cysteine to still bind metal in adjacent coordination spheres of a planar complex.  Although the 
CGC within the sequence of ACS binds to nickel in a 2N:2S geometry, it does not have electron 
transfer properties and therefore catalytic activity.50,73 
 
1.8.2. Cleavage of DNA with an ATCUN motif 
!
 A number of proteins have an N-terminal GGH motif.  Histidine in this third position 
allows the protein to bind metal in a square planar, 4N arrangement with the N-terminus, the 
histidine side chain, and two amide backbone nitrogens acting as ligands.  This motif, termed 
amino terminal CuII, NiII-binding (ATCUN) motif, was first discovered in the protein human 
serum albumin.74-76 The simple peptide GGH is sufficient for metal binding in this geometry,77 
though different residues can be substituted for one or both of the glycines to modulate the 
binding and reactivity of the complex. The metal binds specifically and tightly, but upon 
interaction with the appropriate ligands, the sequence can release its metal, which is important 
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for its role in metal transport in albumins.76 The sequence may also bind metal and play a 
structural role when it is found within the sequence of a protein rather than at a terminus.78 
Additionally, this sequence can be engineered into proteins for various purposes.76 Both the 
copper and nickel forms of this peptide are capable of catalyzing various chemistries.  
Specifically, copper is known for its ability to cleave DNA and even to be an anticancer agent. 
Nickel can mediate specific, oxidative protein cross linking to a tyrosine residue within the 
protein or with nearby proteins.79,80,81 Ni-ATCUN can also perform DNA cleavage.82 The 
cleavage is dependent on nickel-mediated oxidation, which can be activated with several 
different oxidants.83 The nickel is likely oxidized to nickel(III) and in the presence of hydrogen 
peroxide, produces hydroxyl radicals and superoxide.76 The reactivity is driven by involvement 
of metal-associated reactive oxygen species, generated by the NiII/NiIII redox couple. Like Ni-
SOD, this 4N coordinated Ni-peptide allows for cycling between NiII and NiIII, but the result is 
generation of ROS rather than antioxidant activity. The coordinated ROS then acts to cleave the 
DNA bond.  When a lysine is placed in the first position, KGH, the reactivity towards DNA is 
increased, likely due to the increased sigma donor character of lysine versus glycine; the ability 
of the oxygen species to be coordinated to the nickel and for it to be in position to react with 
DNA drives its reactivity.84 Additionally, Ni-GGH can react with other compounds, such as 
sulfate, in solution to promote radical chemistry. In the presence of Ni-GGH, sulfur(IV) in the 
presence of air oxidizes the nickel(II) to nickel(III). Nickel(III) then oxidizes sulfate in solution 
to SO3
·-, which reacts with dioxygen and propagates a radical reaction that is damaging to DNA 
in solution.85 
When cysteine is present in the first position of an ATCUN motif (CXH) in sequences 
where an N-terminus is not available, the nickel binds with 3N:1S coordination, utilizing the 
cysteine side chain as a ligand.  If the thiolate group is blocked, it still binds nickel, and utilizes 
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the N-terminus as a ligand to accomplish 4N, square planar geometry with nickel(II). 
Interestingly, this peptide-metal complex with 4N coordination exhibits quasi-reversible redox 
behavior with a potential of 791 mV vs. Ag/AgCl.  When nickel is bound via sulfur ligation, only 
irreversible oxidation is observed.  When neither the thiol side chain nor the N-terminus is 
protected, pH drives the metal coordination. At neutral pH and anaerobic conditions, the thiolate 
coordination was allowed, but in the presence of air, the complex formed disulfide-linked nickel-
peptide species. At higher pH, nitrogen replaces the sulfur ligand, and the deprotonated thiol is 
free to form a disulfide bond, generating disulfide-linked nickel-peptide complexes. When the 
nickel is bound with 4N geometry, a nickel(III) intermediate forms, followed by formation of a 
thiol radical.  The thiol radical reacts with oxygen to form a thiol peroxyl radical and rearranges 
to a sulfonyl radical, propagating the radical reaction and leading eventually to sulfinic acid 
formation.86 Preferential oxidation of the sulfur ligand rather than nickel is common, and 
understanding what drives thiol oxidation instead of metal oxidation is still of great interest.87 
In general, when a cysteine precedes a histidine residue within a polypeptide, metal 
coordination depends on neighboring residues.  In most cases, the resulting nickel complex is 
square planar, 3N:1S, where the cysteine side chain, the imidazole side chain of the histidine, 
and adjacent backbone nitrogens act as ligands.  In cases where the CH sequence is near the N-
terminus, metal preferentially binds in an all-nitrogen, ATCUN-like arrangement and forgoes use 
of the cysteine side chain.88 
 
1.8.3. Intramolecular cleavage of nickel-bound peptides 
!
 One nickel-peptide complex, bound in 4N, square planar geometry, has been shown to 
promote hydrolysis of the peptide backbone at neutral/basic pH.  Histone H2A containing the 
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sequence –TETHHK– was shown to promote backbone hydrolysis before the second Thr 
residue, though it was less than 50% complete over 140 hours.89 Peptides with the embedded 
sequence (S/T)XHZ (where X and Z are bulky, hydrophobic residues, specifically SRHW) 
undergo hydrolysis in the presence of nickel selectively at the Ser/Thr backbone position over 
the course of hours, showing that differences in the sequence can modulate the rate of the 
reaction.90 Nickel is coordinated by the histidine side chain and the three preceding backbone 
nitrogens, forming a 4N, square planar complex.  It is thought that the binding of nickel in this 
position destabilizes the peptide bond between serine and the residue on its N-terminal side, 
promoting an N-O acyl shift with the OH group on the serine to form an intermediate ester, 
which hydrolyzes to generate the cleaved peptide. This reaction emanates from metal-induced 
steric cleavage rather than redox chemistry, as bulkier residues enhance the rate of cleavage of 
the peptide backbone.91 Cysteine can also anchor the metal binding site, generating a square 
planar, 3N:1S complex where nickel is bound with the cysteine side chain and the preceding 
three backbone nitrogens. The SRCW-containing peptide can also perform the reaction, though 
with reduced efficiency.92 
 
1.9. Structure/function relationship of nickel systems and comparison to MAP 
 
1.9.1. Differences in coordination environment drive reactivity 
!
 Like the nickel enzymes, nickel chaperones and proteins involved in the biosynthesis of 
nickel enzymes utilize a wide variety of approaches to coordinate nickel, including deprotonated 
backbone nitrogens.93 While it was previously believed that sulfur ligation was reserved for 
catalytic nickel centers,5 the discovery and characterization of so many nickel metallochaperones 
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has altered thinking.  The nickel-binding proteins UreE,38,94-97 CooJ, 38,98-100 and RcnR4 all utilize 
nitrogen and oxygen ligands to coordinate the metal. CooC binds with a CXC motif, where two 
monomers come together to provide 4S ligation of the nickel center, and this 4S configuration 
confers tight binding. The protein transfer process is therefore necessarily aided by ATP, which 
upon binding enables separation of the two monomers, facilitating release of the nickel.7,101!
Three nickel-binding proteins are involved in hydrogenase biosynthesis, HypA, HypB, 
and SlyD.  HypA binds nickel with micromolar affinity with four nitrogen ligands in a square 
planar geometry.38,102-104  HypB binds nickel much more tightly with 3S:1N coordination and only 
releases its metal upon interaction with SlyD.103,104  SlyD has a tail containing several Cys-Cys 
pairs and histidine residues, which accomplish binding to seven nickel ions, the structure of 
which has yet to be determined.  In the absence of HypB, nickel cannot bind in all seven sites, 
suggesting that transfer is required for proper incorporation.105,6 Moreover"!despite the use of 
sulfur ligation, catalysis has not been reported.  In general, in the pathway of nickel insertion, the 
affinity for nickel successively increases with each protein. 
Studies reported to date do not explain why sulfur ligation sometimes allows catalysis 
and other times does not. For example, it is not clear what makes Ni-SOD catalytically active 
when it is analogous in structure to nickel proteins that do not catalyze reactions. Ni-SOD and 
the distal nickel of Ni-ACS have the same cis, 2N:2S coordination geometries, but while Ni-
SOD is able to transfer electrons, the distal nickel of ACS is not. The distal nickel of ACS is 
present only to tune the reactivity of the proximal active site. This again emphasizes the 
importance of the overall protein structure and nearby structural motifs that impact reactivity. 
HspA also binds nickel with 2N:2S geometry, using a CC sequence; despite similarities to the 
active site structure of Ni-SOD, SOD activity has not been reported.38,106,107 Differences among 
these proteins provide evidence that the coordinating ligands, binding geometry, as well as 
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overall protein structure all contribute toward the promotion of electron transfer and control of 
reactivity. 
 Though proteins with cysteine residues have been reported to bind metal, the geometry 
and chemistry of the Ni-NCC motif is unique.  Of previously reported Ni-binding sequences that 
contain geminal Cys,105,107,108 no SOD activity and only minimal structural characterization have 
been reported.  The Ni-SOD maquettes do not contain contiguous Cys, yet MAP recapitulates the 
coordination and activity using adjacent Cys residues. Another tripeptide, the ATCUN motif, has 
the same geometry but carries out electron transfer in the absence of sulfur ligands, which leads 
to the generation of reactive oxygen species. The NCC tripeptide neutralizes rather than 
generates ROS, providing an additional tool for characterizing inner sphere effects. Additionally, 
in this work, we have noted the significance of the method of metal insertion, which requires 
transfer from a weak chelator to incorporate metal into the arrangement that is capable of 
productive electron transfer.  Such a metal transfer reaction has not previously been described in 
the formation of other metal-peptide complexes.  As such, this reaction may aid in understanding 
the mechanism of transfer within metallochaperone pathways, such as the transfer of nickel 
between HypB and SlyD.  
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Chapter 2:  A Novel Tripeptide Model of Nickel Superoxide Dismutase 
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The radical species superoxide (O2
·-) and its reactive downstream products are known to 
cause oxidative damage to biological molecules, and the presence of superoxide in the body has 
been linked to many different diseases.1 Superoxide dismutases (SODs) are oxidoreductases that 
catalyze the disproportionation of superoxide to hydrogen peroxide and molecular oxygen, 
therefore helping to protect biological systems from oxidative damage. These enzymes, 
classified by their metal center, include Cu/Zn-SODs, Fe- and Mn-SODs, and Ni-SODs.2 
Ni-SOD is the most recently discovered form of the enzyme.3,4 Its active site contains a 
mononuclear nickel center5 coordinated in square planar geometry at the N-terminus of the 
enzyme via two cysteine sulfurs (Cys-2 and Cys-6), an amine nitrogen from the N-terminus, and 
a deprotonated, anionic amide nitrogen from the peptide backbone (Cys-2).6,7 Ni-SOD reacts 






As part of the redox reaction, the geometry of the bound nickel switches from square 
planar NiII to square pyramidal NiIII. An additional ligand, an axial nitrogen donor, coordinates 
Scheme 2.1.  Reaction catalyzed by Ni-SOD. 
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NiIII in the resting state,3 and the X-ray crystal structure revealed this species to be the imidazole 
nitrogen of His1. Upon reduction of the enzyme, the histidine imidazole rotates away from the 
active site, leaving NiII coordinated in 2N:2S, square planar geometry.6,7,9 
While much has been learned about the structure of the enzyme, only recently have 
studies begun to reveal more about the influence of the secondary coordination sphere.10,11 While 
recent studies support an inner sphere mechanism,12,13 the catalytic mechanism is not yet fully 
elucidated. In order to further explore these issues, it has been of interest to develop model 
systems that mimic the activity of this enzyme. Within Ni-SOD, the metal is coordinated by 
ligands found within the first six residues of the N-terminus.6,7 Synthetic models with square 
planar 2N:2S geometries have appropriate redox potentials to act as SOD mimics, yet these do 
not exhibit SOD activity.14-16 Peptide models based on the terminal sequence of the enzyme, 
however, have been shown to mimic SOD activity.12,13,17-19 Here we present a novel tripeptide 
mimic, asparagine-cysteine-cysteine (NCC), that exhibits both quasi-reversible NiII/NiIII 
transitions and SOD activity. (Jennifer Ann Stowell Laurence, Anthony Andrew Vartia, Mary 
Elizabeth Krause. METAL ABSTRACTION PEPTIDE (MAP) TAG AND ASSOCIATED 
METHODS.  Provisional Patent Application USPTO 61/052,918. Filed May 13, 2008. 
International Patent Application PCT/US2009/43821. Filed May 13, 2009. Published September 
10, 2010.) NCC is unique because it is not derived from the sequence of the parent enzyme. 
Because of its small size, this tripeptide is likely to have better stability and lower cost of 
production than larger peptide alternatives. Importantly, using an alternative simple model also 
has the potential to shed insight into the minimal geometric/electronic features necessary for 







2.1.1. Generation of Ni-NCC complex: The NCC peptide was purchased from Genscript 
Corporation (Piscatway, NJ, USA).  The Ni-NCC complex was generated using a 
transmetallation reaction performed in aqueous solution at neutral to basic pH.  Incubation of the 
peptide for approximately 30 minutes with immobilized metal affinity chromatography (IMAC) 
resin (GE Healthcare) charged with nickel ensures a clean reaction with no undesired side 
products and no free metal ions in solution, yielding a reddish-brown complex.  
 
2.1.2. ESI-MS:  Samples were diluted 100x in methanol and analyzed on an LCT Premier 
(Waters Corporation) operating in negative ion mode.  In order to verify that no changes were 
made to the peptide upon release of the metal, samples were acidified to approximately pH 5 by 
addition of 1 M hydrochloric acid (HCl) and analyzed using the same technique.    
 
2.1.3. CD and absorption studies:  A 1.5 mM solution of Ni-NCC was prepared in 50 mM 
sodium phosphate, pH 7.4, sparged with argon.  Immediately after incubation, samples were 
placed in a cuvette with a 1-cm path length and scanned from 900-300 nm using both absorption 
and CD spectroscopy.  Background scans of buffer alone were subtracted from each scan.  
Absorption studies were performed on an Agilent 8453 UV/Visible spectrophotometer.  Circular 
dichroism analysis was performed on a J-815 (Jasco Corporation).  The data presented are the 




2.1.4. Deconvolution:  Deconvolution of CD and absorption data was performed using Igor Pro 
(Wavemetrics).  Iterative Gaussian deconvolutions were performed with a constant peak width of 
1650 cm-1.  Absorption band energies were kept within 10% of the corresponding CD bands due 
to the broad nature of the absorption spectrum. 
 
2.1.5. DFT: DFT calculations were performed by A. Glass. The ORCA 2.7 software package 
designed by Neese and coworkers was used for all DFT computations.20Spin restricted geometry 
optimizations were converged to the S = 0 spin state and employed the Becke-Perdew (BP86) 
functional,21,22 and the aug-TZVP (Dunning diffuse functions added to Ahlrichs triple-x valence 
polarized) basis in conjunction with the TZV/J auxiliary basis for all atoms.23,24 These 
calculations employed the resolution of identity (RI) approximation developed by Neese.25 
Solvation effects associated with water (# = 80) were incorporated using COSMO, as 
implemented in ORCA.26 Subsequent single-point energy calculations on the geometry-optimized 
structures employed the B3LYP functional,27,28 the aug-TZVP basis,29 and the COSMO solvation 
model. 
 
2.1.6. pH titration: The absorption of the complex was monitored over a pH range of 7.4 to 10 to 
confirm that no structural changes result from pH adjustment. As observed with similar 
systems,30  the peaks observed at pH 7.4 increase in intensity with increasing pH.  To monitor the 
dependence of absorption intensity on pH, a sample containing 1.5 mM Ni-NCC was prepared in 
50 mM borate at pH 10, sparged with argon.  After incubation, the pH was adjusted back to 10 
and the CD and absorption spectra were measured as described above.  pH was lowered in half-
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log increments (pH 9.5, 9.0, 8.5, 8.0, and 7.4) using 1 M HCl, and CD and absorption spectra 
were collected at each pH point.   
 
2.1.7. MCD: Samples containing 6 mM Ni-NCC were prepared in 50 mM borate at pH 10, 
sparged with argon.  Solid sucrose was added as a glassing agent and the mixture was heated to 
form a saturated solution.  The dilution resulted in a final Ni-NCC concentration of 2 mM.  The 
sample was placed in an MCD cell and flash frozen.  Spectra were collected by A. Glass on a J-
815 (Jasco Corporation) interfaced with an Oxford Spectromag 4000.    Spectra were collected at 
+7 and -7 Tesla and the difference was found via subtraction in order to remove any CD signal.   
Spectra were collected at 15 K, 8 K, 4.5 K, and 2 K and analyzed to identify any changes in the 
spectra that indicate paramagnetic character.  The feasibility of correlating these low temperature 
data with the structure of Ni-NCC at room temperature is demonstrated by the lack of apparent 
changes in the corresponding CD spectra collected at 298 and 4.5 K.  
 
2.1.8. Solid phase peptide synthesis:  The peptides GCC, GGGCC, and GGNCC were 
synthesized in house using solid phase peptide synthesis on Wang resin using Fmoc protected 
amino acids and HBTU/DIPEA coupling techniques.  Wang resin and Fmoc-protected amino 
acids were purchased from Novabiochem and used as received.   The peptide was cleaved from 
the resin using Reagent R (90% TFA/5% thioanisole/3% EDT/2% anisole).  The resulting 
solution was added dropwise to cold diethyl ether to precipitate the peptide.  The cleavage 
solution was washed several times with cold ether and the resulting crude peptide was purified 
by preparative reverse phase HPLC  (Shimadzu) with a C18 column  (Varian Microsorb 300 
C18; 8 µM, 250 x 21.4) and guard column (Varian Microsorb 300 C18; 8 µM, 50 x 21.4).  The 
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fractions containing the purified peptide were lyophilized and the mass was verified by ESI-MS.   
 
2.1.9. Electrochemical studies:  A 3-mL, 3-mM Ni-NCC sample was prepared in 50 mM borate 
at pH 10.  Cyclic voltammetry (CV) data were collected with a CHI812C Electrochemical 
Analyzer potentiostat (CH Instruments) with a three-electrode setup (platinum working 
electrode, Bioanalytical Systems Inc.; Pt auxiliary electrode; Ag/AgCl reference electrode) in a 
glass CV cell.  Potential was applied from zero to 1.2 V with a scan rate of 0.2 V per second, and 
current was measured. Bulk electrolysis was performed on a 3-mL, 3-mM Ni-NCC sample 
prepared in the same manner.  Using the same setup as the CV measurements, potential was 
applied at 0.95 V while stirring to fully oxidize the sample, and current was monitored until no 
further change was observed.  ESI-MS operating in negative ion mode was performed on the 
sample following bulk electrolysis to confirm the peptide was unaltered.  
 
2.1.10. Xanthine/xanthine oxidase SOD activity assay:  An assay using xanthine/xanthine 
oxidase was performed as described by Crapo et al.32 with minor modifications.  The assay was 
performed in 50 mM potassium phosphate with 100 µM EDTA at pH 7.8.  In this assay, 600 µM 
cytochrome c from bovine heart (Sigma), 300 µM xanthine (Sigma), and enough xanthine 
oxidase (from buttermilk; Sigma) to cause a change in absorbance at 550 nm of 0.02 AU to 0.04 
AU per minute were added to a final volume of 300 µL, and the change in absorbance at 550 nm 
was monitored on a Cary 100 UV-visible spectrophotometer (Varian).  The assay was performed 
with several concentrations (0, 10, 15, 20, 25, 30, 35, 40, 50 µM and beyond as necessary) of Ni-
NCC to measure an IC50 value.   
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2.2. Results and Discussion 
NCC binds nickel, apparently with extremely high affinity at physiological pH, and this 
system is thought to be a potential mimic of Ni-SOD based on similarities in coordination. To 
show the extent of incorporation of metal into the complex and assess changes in protonation of 
the free versus bound peptide, electrospray ionization mass spectrometry (ESI-MS) operating in 
negative ion mode was used. The data show full incorporation of the metal in a 1:1 ratio and 
suggest that no irreversible modifications to the peptide occur upon incorporation or release of 
the metal via acidification. These data further indicate a tetra-deprotonated species binds the 
metal ion (Ni-NCC = 392.98). 
To probe the NiII geometry in more detail, electronic absorption, circular dichroism (CD), 
and variable-temperature magnetic CD (MCD) data were collected for Ni-NCC.  Supporting the 
mass spectrometry data, absorption spectra collected over a broad range of concentrations of the 
complex resulted in an increase in band intensity, indicating that there is one primary species 
present in solution (data not shown).   Signal intensity also varies with pH, where the low energy 










Figure 2.2. CD of a pH titration of Ni-NCC in 50 mM borate.  The 
bold line represents the highest pH (10.0) and the solid line 
represents the lowest pH (7.4).  Dashed lines represent other pH 
values measured (pH 9.5 – 8.0), in which the peaks are reduced in 
intensity with each half-log decrease in pH.  
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An iterative deconvolution of the absorption and CD spectra reveal seven electronic 
transitions between 14 000 and 29 000 cm-1 (Table 2.1 and Figure 2.2). With the exception of 
band 1, the energies of these transitions are within ~1000 to 2000 cm-1 of those reported for Ni-
SOD (Table 2.2), which is indicative of structural similarities between the NiII centers in these 
two systems. Bands 1 – 4 of Ni-NCC, which are relatively intense in the CD spectrum but carry 
only moderate absorption intensities, are assigned as the four d-d transitions expected for a 
square planar NiII center. By analogy to Ni-SOD, we assign the higher-energy bands 5 – 7 as 
thiolate-to-nickel(II) charge transfer (CT) transitions.  
 














 Absorption CD 
Band Energy (cm-1) # (M-1cm-1) Energy (cm-1) $# (M-1cm-1) 
1 14 500 20 14 200 -0.1 
2 17 300 60 16 270 -0.21 
3 19 650 160 18 900 0.22 
4 21 850 205 22 170 0.64 
5 24 300 275 23 900 -0.44 
6 26 850 575 26 520 0.71 




















Table 2.2. Comparison of Ni-NCC and Ni-SOD CD transition energies and assignments. 











 d-d 14 200 17 110 
2 Ni
II
 d-d 16 270 18 430 
3 Ni
II
 d-d 18 900 20 500 
4 Ni
II















 CT 28 475 29 220 
 
Further support for the presence of a square planar NiII center in Ni-NCC comes from the 
temperature independence of MCD signals observed for Ni-NCC over the temperature range 2 – 
15 K (Figure 2.3). This behavior is indicative of a diamagnetic (S = 0) species, which is best 
Figure 2.2.  Deconvoluted CD (top) and absorption (bottom) spectra of 
1.5 mM Ni-NCC in 50 mM phosphate buffer, pH 7.4. Spectra were 
deconvoluted with Igor Pro (Wavemetrics). The sum of the deconvoluted 





































 Experimental CD spectrum
 Individual deconvoluted Gaussian bands
 Sum of deconvoluted Gaussian bands
 Experimental absorption spectrum
 Individual deconvoluted Gaussian bands
 Sum of deconvoluted Gaussian bands
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rationalized in terms of a square planar NiII center.34  Room temperature and low temperature CD 
spectra are parallel (Figure 2.4). The only changes between these two spectra are the expected 
blue-shifts and sharpening of the bands in the spectrum collected at 4.5 K. The percentage of 
paramagnetic species was determined by comparing the MCD intensity of the most intense 
feature in our spectrum to a purely paramagnetic tetrahedral NiII species (NiII-substituted 
rubredoxin) at comparable field (5T) and temperature (4.5K) in $# (M-1cm-1).  Qualitatively, our 
most intense feature occurs at 26 000 cm-1 with an intensity of ~1 M-1cm-1. In comparison, in the 
tetrahedral NiII-substituted rubredoxin MCD spectrum, the most intense feature at 23 000 cm-1 
has an intensity of > 100 M-1cm-1.31 Therefore, under the assumption that the paramagnetic 
species observed for Ni-NCC has a similar $# value, this species represents approximately less 
than 1% of the overall sample. 
 
!
Figure 2.3. Variable temperature, 7 T MCD difference of Ni-NCC in a 34:66 solution of 50 mM borate:sucrose.  
Spectra show very little temperature dependence.  (The solid red line represents data collected at 2 K, the dotted 

































   
 Based on the data presented above, nickel is coordinated in a square planar 2N:2S geometry. In 
Ni-SOD, the thiolate ligands are cis and the nitrogen ligands include one amide and one amine.33 
Our current studies support a possible arrangement that parallels the coordination by Ni-SOD in 
which the two sulfur ligands are arranged cis and one nitrogen is derived from a backbone amide 
while the second is from the N-terminal amine (Figure 2.5).  DFT computations20 show that this 
proposed structure has the lowest total energy when compared with other potential structures 










Figure 2.4. Room- and low-temperature CD spectra.  The 4.5 K and 298 K spectra are 
represented as dashed and solid lines, respectively. 
Figure 2.5. Metal coordination in Ni-SOD (right) and the 
proposed coordination in Ni-NCC (left).  Wavy lines 




Table 2.3. Energies of converged structures of Ni-NCC in various conformations.  The lowest energy conformation 
corresponds to Ni-NCC with cis-thiolates and the backbone amide and N-terminal amine nitrogens involved in 
coordination. Relative energies versus the lowest energy model (cis-proximal) are listed in kcal/mol.  Nitrogen 
atoms are color coded to be consistent between models.  !
cis-proximal trans-mixed 
(0 kcal/mol) (+9.4 kcal/mol) 
  
cis-distal trans-bis-amide 
(+23.6 kcal/mol) (+33.7 kcal/mol) 
  
  

















































To probe whether or not the Asn side chain is involved in NiII coordination, the tripeptide GCC 
was synthesized and transmetallated. The observation that the Ni-GCC spectra parallel those of 
Ni-NCC supports the structure proposed above, where the Asn side chain is not ligated to the NiII 
center.  GGNCC and GGGCC peptides were also synthesized to further examine the identity of 
the nitrogen ligands in Ni-NCC. The spectral features of the pentapeptides are similar to each 












This suggests the N-terminal amine participates in metal coordination in the tripeptides. 
Presumably, the N-terminal amine in the pentapeptides is too far removed from the NiII center to 
act as a ligand and the backbone amide nitrogen from the Asn substitutes for the terminal amine 
nitrogen to accomplish metal binding. Additionally, it is thought that mixed amine/amide 
coordination species are more stable to oxygenation than bis-amide species,15 and the observation 
Figure 2.6. CD and absorption spectra of Ni-NCC, Ni-GCC, Ni-GGNCC, and Ni-GGGCC in 50 mM 
borate, pH 9.3.   Differences in intensity reflect different abilities of the peptides to pick up metal, 




that Ni-NCC does not experience oxidation of the S ligands is further evidence for the proposed 
mixed amine/amide coordination.  Similarities in the chemistry (vide infra) support the use of 
Ni-NCC as a model system for understanding the catalytic mechanism of Ni-SOD. 
  Because the studies above demonstrate that Ni-NCC serves as a reasonable structural 
mimic of Ni-SOD, the midpoint potential of Ni-NCC was measured using cyclic voltammetry 
(CV). CV data show electron transfer is quasi-reversible, with a midpoint potential of 0.72(2) V 
versus Ag/AgCl (Figure 2.7), which is similar to the 0.70(2) V measured for a peptide mimic 
based on the sequence of the parent enzyme with mixed amine/amide coordination and cis 
ligation [Ni(SOD)M1].17 Ni-SOD has a midpoint potential of 0.290 V (NHE, 0.093 versus 
Ag/AgCl).10 The quasi-reversibility of the CV data indicate structural changes upon 
oxidation/reduction, which is rationalized in terms of the different geometries preferred by NiII 
and NiIII centers.  
!
Figure 2.7.  CV of Ni-NCC in 50 mM borate, pH 9.3, with a scan rate of 0.2 V per second.   
Electrochemically, the system is quasi-reversible (Em= 0.72(2) versus Ag/AgCl.) 
!
  To confirm that electron transfer does not alter the peptide and that the measured 
potential specifically reflects a change at the nickel ion, ESI-MS was collected after performing 


















peptide is unaltered. Therefore, the redox potential measured corresponds to the NiII/NiIII redox 
couple. Because the midpoint potential of the Ni-NCC complex falls between the reduction and 
oxidation potentials for superoxide, the ability of Ni-NCC to dismutate the reactive superoxide 
species was examined.     
  A standard SOD activity assay using xanthine oxidase was performed.32,35 The data show 
that Ni-NCC does exhibit SOD activity, but it is slower than Ni-SOD.  The IC50 for Ni-NCC (4.1 
± 0.8 x 10-5 M; Figure 2.8) is comparable to those values reported for other peptide mimics, 













Figure 2.8. Representative IC50 plot for Ni-NCC in the xanthine/xanthine oxidase SOD activity assay.  
 
Because the reduction potential of Ni-NCC is similar to that of [Ni(SODM1], but the 
activity of Ni-NCC is lower than this amine/amide maquette (2.1 x 10-7 M),18 the rate may be 
decreased by the absence of a fifth ligand in the Ni-NCC complex.  For Ni-SOD, it has been 
suggested that the axial imidazole ligand tunes the redox properties of the NiIII species to be 
appropriate for superoxide dismutation.19,33 In follow-up studies to be presented elsewhere, 
examination of the system in the presence of anions showed that Ni-NCC coordinates a transient, 
anionic fifth ligand, further supporting its similarity to Ni-SOD.  
IC50 Ni-NCC

















  Ni-NCC exhibits similar features to Ni-SOD, and its midpoint potential and ability to 
break down superoxide support its use as a mimic of the enzyme. The sequence of this novel 
peptide mimic is unrelated to that of Ni-SOD and provides a complementary system for 
understanding how the identity and geometry of the supporting ligands influence not only the 
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Chapter 3: MAPping the Chiral Inversion and Structural Transformation of 
a Metal-Tripeptide Complex having Ni-SOD Activity 
Reproduced with permission from:  
Krause, M.E.; Glass, A.M.; Jackson, T.A.; Laurence, J.S. MAPping the Chiral Inversion and Structural 
Transformation of a Metal-Tripeptide Complex Having Ni-Superoxide Dismutase Activity, Inorg. Chem. 2011, 50, 
2479-2487. 
Copyright 2011 American Chemical Society. 
http://pubs.acs.org/articlesonrequest/AOR-WJPbw2xcuAfDjifH4EZX!
The metal abstraction peptide (MAP) is a tripeptide, here with the sequence Asn-Cys-Cys 
(NCC).1 A reaction with IMAC resin-chelated nickel allows this NCC peptide to react with and 
abstract the metal, resulting in a high affinity Ni-peptide complex at neutral pH. The nickel-
bound peptide, Ni-NCC, contains a diamagnetic NiII center bound in square planar geometry 
(Figure 3.1) with 2N:2S coordination.1 Computational analysis determined the structure of Ni-
NCC has mixed amine/amide nitrogen coordination and cis deprotonated thiolates.  This 
coordination is very similar to that of Ni in the enzyme nickel superoxide dismutase (Ni-SOD), 
which consists of two cysteinate sulfurs (Cys2 and Cys6) arranged cis to one another, the N-
terminal amine, and the deprotonated amide nitrogen from the peptide backbone of Cys2.2-4 
When bound to nickel, the tripeptide acts a functional mimic of the enzyme nickel superoxide 
dismutase.1 The reaction catalyzed by Ni-SOD is unusual as it employs oxidation-prone thiolate 
ligands to bind the redox-active Ni ion.  Metal-centered redox cycling between the NiII and NiIII 
states is necessary to afford Ni-SOD activity.  Coordination of the metal ion in the protein shifts 
between square planar (NiII) and square pyramidal (NiIII) and leaves one face of the Ni ion open 
to solvent or substrate binding and enzymatic turnover. Complementary studies of the 
spectroscopic properties and reactivities of maquettes derived from a sequence of Ni-SOD have 
provided additional insights into the structure and mechanism of Ni-SOD.5-9 
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Our previous studies allowed the determination of ligands to the metal and the overall 
geometry of the Ni-NCC complex; however, a stability study has further revealed that the metal-
tripeptide complex undergoes chiral inversion in a site-specific manner. (Jennifer Ann Stowell 
Laurence, Mary Elizabeth Krause, Timothy A. Jackson. SITE-SPECIFIC CHIRAL INVERSION 
OF THE AMINO ACIDS.Provisional Patent Application USPTO 61/432,231. Filed January 13, 
2011.) This modification is distinctive, as chiral inversion is not often observed in proteins, and 
the structural change that occurs in this complex is both site and structurally specific.  This chiral 
change has not been reported to occur in Ni-SOD or in small peptide maquettes derived from the 
N-terminal sequence, which contains the metal-binding loop.  Amino acids and dipeptides are 
known to undergo base-catalyzed racemization at the chiral !-carbon as a result of metal 
chelation, but inversion is typically accomplished over several hours at highly elevated 
temperature (>90 ˚C) and basic pH (>9).10-14 Studies performed on metal-amino acid chelates in 
deuterated solvent reveal that approximately an equal proportion of L and D isomers are 
generated during such reflux reactions in the absence of strong conformational influences. 
Because of the need for such extreme conditions, this type of reaction is not relevant to proteins 










Figure 3.1.  Chemical structure of Ni-NCC showing the 
square planar arrangement of 2N:2S coordination 






The D amino acids that have been observed in proteins and peptides often impart 
significant differences in biological function to the chiral peptide and protein variants; while 
some act as inhibitors, others act as activators.15 The introduction of a D amino acid alters the 
structure of the peptide or protein,16 which can in turn influence the biological activity of the 
parent peptide.17,18 Conversely, chiral mutagenesis of proteins has been shown to stabilize 
certain proteins, including insulin.19 All naturally occurring, biosynthetic peptides and proteins 
that contain D amino acids are first generated entirely from L amino acids, and the inversion 
occurs as a post-translational modification.  
 Three major methods of incorporation of D amino acids have been reported, and the 
majority of D amino acids are found within three amino acids of the N- or C-terminus.  First, if 
the placement of the D amino acid is intentional, it is enzyme catalyzed by amino acid 
racemases.15 While most of these racemases employ a pyridoxalphosphate cofactor and proceed 
through a Schiff-base intermediate, some are thought to follow a different mechanism that does 
not require this cofactor. Reported examples of known enzyme-catalyzed epimerization include 
an enzyme from the venom of the funnel web spider that catalyzes the conversion of Ser-46 to D-
Ser 46 within a 48 residue peptide (%-agatoxin IV),15,18 an enzyme isolated from the skin of a 
frog (Bombina) that incorporates a D-amino acid into the second position of the substrate,15,20 and 
a mammalian enzyme from platypus venom that has specific, but not completely known, 
substrate requirements.21 
The only other reports of D amino acids in mammalian proteins are in aged tissues, and 
these aging proteins have been shown to contain D amino acids, largely at aspartic acid residues, 
which are prone to racemization.15,22 Examples of proteins and peptides containing D-Asp from 
this type of reaction include human lens alpha A-crystallin,23 human lens alpha B-crystallin,24 
and beta-amyloid protein in the brain.25 The presence of the D-Asp influences the behavior of the 
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peptide and its effect on neurodegeneration in Alzheimer’s patients.26 These spontaneous 
inversions of chirality arise from a mechanism involving cyclization and hydrolysis reactions, 
where the nearby environment of the protein helps initiate and drive the conversion.22 
The mechanisms described above are reversible reactions, but conversion of an amino 
acid from L to D chirality within proteins has also been reported to proceed via a free radical 
reaction, in which cysteine residues are involved in the electron transfer.27 These reactions are 
light-driven and unidirectional.  The cysteinyl radical is generated by intense UV light and 
subsequently abstracts hydrogen from a surrounding amino acid, leading to epimerization.27-30 
The selectivity determining where the reaction occurs is controlled by the secondary structure of 
the peptide or protein, leading to a variety of different products, depending on the context.28 
Despite the limited number of examples of site-specific L to D conversions that have been 
reported, the literature reveals that diverse mechanisms are used to accomplish chiral inversion.  
To our knowledge, we report here the first site-specific chiral inversion of amino acids that 
depends on metal binding. The reaction proceeds at room temperature and near neutral pH in 
aqueous solution over the course of hours. While NCC was synthesized to contain all L amino 
acids, conversion to the D-containing form occurs after complexation with nickel, and the 
reaction results in inversion at two positions to produce the stable DLD-NCC-metal complex. The 
resulting DLD-peptide-metal complex is very stable in aqueous solution, and DFT calculations 




3.1.1. Generation of metal-peptide complexes:  The peptides NCC, GCC, and NCC with a D-
cysteine in the middle position [LDL-NCC] were purchased from Genscript Corporation 
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(Piscatway, NJ, USA).  The NCC peptides with a D-cysteine in the third position [LLD-NCC] and 
with both D-asparagine in the first position and D-cysteine in the third position [DLD-NCC] were 
purchased from Neo-Peptide (Cambridge, MA, USA).  Nickel-peptide complexes were 
generated in aqueous, argon-sparged solutions at neutral to basic pH.  Incubation of the peptide 
for approximately 30 minutes with immobilized metal affinity chromatography (IMAC) resin 
(GE Healthcare) charged with nickel ensures a clean reaction with no undesired side products 
and no free metal ions in solution, yielding a reddish-brown complex, varying slightly by the 
identity of the peptide.  Aged Ni-NCC samples were allowed to age for >40 days.     
 
3.1.2. CD and absorption studies:  A 1.5 mM solution of Ni-NCC was prepared in 50 mM 
potassium phosphate, pH 7.4.  Immediately after incubation, samples were placed in a cuvette 
with a 1-cm path length and scanned from 800-300 nm using both absorption and CD 
spectroscopy. Samples were aged and monitored at various time points over the course of several 
days.  Background scans of buffer alone were subtracted from each scan.  Absorption studies 
were performed on an Agilent 8453 UV/Visible spectrophotometer.  Circular dichroism analysis 
was performed on a J-815 (Jasco Corporation) spectropolarimeter.  The CD data presented 
represent the average of at least five scans.  To accurately control the time frame of Ni-NCC 
aging for activity assays, the complex also was formed in solution upon addition of one 
equivalent of NiSO4.   
 
3.1.3. MCD experiments: Samples of Ni#NCC were prepared in 50 mM potassium phosphate 
buffer at pH 7.4 sparged with argon. Solid sucrose was added as a glassing agent and the mixture 
was heated to form a saturated solution. CD spectra of sucrose-saturated samples demonstrated 
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no significant changes in features compared with samples lacking sucrose, indicating that this 
procedure did not perturb the structures of the Ni-NCC complex. The samples were placed in an 
MCD cell and flash frozen in liquid N2.  Spectra were collected by A. Glass on a J#815 (Jasco 
Corporation) spectropolarimeter interfaced with a magnetocryostat (Oxford Spectromag 4000-8).  
To remove contributions from CD signals, MCD data reported herein represent difference 
spectra of accumulations at +7 and #7 T.  Because the signal intensities from paramagnetic 
species display inverse temperature dependence, spectra were collected at several temperatures.  
 
3.1.4. Deconvolution of CD and absorption data:  Deconvolution of CD and absorption data was 
performed using Igor Pro (Wavemetrics).  Iterative Gaussian deconvolutions were performed 
with a constant peak width of 1650 cm-1.  Absorption band energies were kept within 10% of the 
corresponding CD bands due to the broad nature of the absorption spectrum. 
 
3.1.5. ESI-MS:  Samples were diluted 100x in a 1:1 mixture of methanol/water and analyzed on 
an LCT Premier (Waters Corporation) operating in negative ion mode, as described previously.1 
 
3.1.6. Deuterium exchange: A solution of 50 mM potassium phosphate was prepared in D2O and 
adjusted with NaOD and DCl to a pD of 7.4.  Samples of 1.5 mM NCC and GCC were prepared 
in this solution.  Metallation was performed as described above.  After removal of the solid resin, 
10 µL of the sample was back-exchanged into one mL of a 1:1 water/methanol mixture and 
analyzed using ESI-MS operating in negative ion mode.  The original samples were then 
incubated for 24 hours and analyzed in the same manner.  
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3.1.7.Electrochemistry: Electrochemical data were collected as previously described.1 A 3-mL 
sample of 3 mM Ni-NCC was prepared in 50 mM sodium borate at pH 10.  CV data were 
collected with a CH1812C Electrochemical Analyzer potentiostat (CH Instruments) with a three-
electrode setup (platinum working electrode, Bioanalytical Systems, Inc.; Pt auxiliary electrode; 
Ag/AgCl reference electrode) in a glass CV cell.  Potential was applied from zero to 1.2 V with a 
scan rate of 0.2 V per second, and current was measured.  The same experiment was attempted 
on a 3 mM Ni-NCC sample in 50 mM potassium phosphate at the same pH.  The sample was 
incubated for 24 hours and analyzed again.   
 
3.1.8. Coordination of cyanide and IR analysis:  Samples of Ni-NCC were prepared at a 
concentration of 3 mM in 50 mM sodium borate at pH 10 and 50 mM potassium phosphate at pH 
7.4.  A sample of Ni-NCC in phosphate buffer was incubated for 24 hours.  One equivalent of 
potassium cyanide was added to each of the three Ni-NCC samples.  Samples were flash frozen 
and lyophilized.  IR analysis was performed to observe the cyanide peak in each sample. IR 
spectra were acquired from dry powder samples on a Perkin Elmer Spectrum 100 FT-IR 
spectrometer equipped with a universal ATR (Attenuated Total Reflection) sampling accessory.  
The spectrum of solid potassium cyanide was used to compare the shift of &(C'N) vibration 
from the free to the nickel-coordinated state.  
 
3.1.9. Computations: Spin-restricted density functional theory (DFT) computations were 
performed by A. Glass using ORCA 2.8.031 and employed the conductor-like screening model 
(COSMO)32 with an epsilon value of 80 to approximate water.  Geometry optimizations used the 
BP86 functional33,34 and the aug-TZVP basis set (a triple-zeta basis set with diffuse and 
polarization functions).35,36 Because these computations employed the resolution of identity (RI) 
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approximation,37 the TZV/J auxiliary basis set was also used.  Single point and time-dependent 
DFT (TD-DFT) computations used the B3LYP38-40 functional and the aug-TZVP basis set. In 
order to evaluate if the inclusion of explicit water molecules H-bonded to charged groups gave 
rise to geometries markedly different than those obtained using COSMO, a water molecule was 
added to hydrogen bond with the C-terminal carboxylate in the LLL, DLD, and DDL models of Ni-
NCC. Because differences in bond lengths of less than 0.015 Å were observed, we reasonably 
conclude that the use of COSMO is sufficient to account for major solvation effects in this 
system. 
 
3.1.10. Ni-SOD xanthine/xanthine oxidase coupled assay: Ni-SOD activity was determined as 
reported previously,1 except Ni-NCC was generated in situ using one equivalent NiSO4.  Ni-NCC 
was aged for 0 – 120 minutes, and the Ni-SOD activity was determined using the standard 
xanthine/xanthine oxidase method developed by Crapo and coworkers.41 All reagents were 
generated in 50 mM potassium phosphate, 100 µM EDTA reaction buffer at pH 7.8 except for 
Ni-NCC, which was generated in 50 mM potassium phosphate, pH 7.4.  In this assay, 600 µM 
cytochrome c from bovine heart (Sigma), 300 µM xanthine (Sigma) and enough xanthine 
oxidase from buttermilk (Sigma) to cause a change in absorbance at 550 nm of 0.02 – 0.04 AU 
per minute were added to a final volume of 300 µL in reaction buffer.  The change in absorbance 
at 550 nm was monitored on a Cary 100 UV-Visible spectrophotometer (Varian).  The assay was 
performed with 100 µM Ni-NCC.  Time points and assays on the D-containing peptide were 







3.2.1. Preparation and spectroscopic characterization of Ni-NCC 
!
 As previously reported, metal incorporation into the described complex is most 
efficiently accomplished via metallation.1 Peptides were incubated with IMAC resin in either 50 
mM potassium phosphate buffer at pH 7.4 or in 50 mM sodium borate at pH 10. Absorption and 
CD spectroscopies were utilized to characterize the Ni-NCC complex. Studies have shown that 
pH, ionic strength, and concentration of the metal-peptide complex do not change the spectral 
features of the system;1 however, these studies show that the initial spectra differ between buffer 
systems (Figure 3.2) but later converge to a common final state. pH is not a factor in the 
differences between spectra, as Ni-NCC samples analyzed in phosphate buffer at pH 10 directly 











Over time, however, the spectral features of Ni-NCC in phosphate buffer change to 
resemble those in borate buffer, suggesting rearrangement to a more stable structure occurs. 
Although samples were prepared in sparged solutions, no further precautions were taken to avoid 
Figure 3.2. CD spectral features of Ni-NCC in different 
buffer systems. (Green=phosphate at pH 7.4, Red = 
borate at pH 10.0). 
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oxygen dissolution during aging.  To ensure complete conversion, a Ni-NCC sample in 
phosphate buffer was aged in air for up to 90 days and analyzed again (Figure 3.3). ESI-MS of 
the Ni-NCC complex in various conditions demonstrated that the peptide mass does not change 
with the changes in spectral features (m/z = 392.98), indicating a lack of oxidation of thiolate 
ligands. Varied pH did not affect the overall rate of the aging process (Figure 3.4).  This suggests 
that the changes observed in the CD are due to more subtle changes about the metal center.  A 
Ni-GCC sample was examined in the same manner to evaluate the influence of the chirality at 
the first position.  Although the spectral changes for the two complexes are not identical, a 
similar perturbation of CD signals was observed for Ni-GCC over a comparable time frame (data 















Figure 3.3.  Aging progression of Ni-NCC in phosphate.  












3.2.2. Spectral deconvolutions 
In contrast to the changes in the CD spectra of Ni-NCC, absorption spectra of Ni-NCC 
freshly prepared in phosphate buffer and that same sample aged for 40 days appear nearly 













).  These data are consistent with 
both species having a four-coordinate Ni
II
 center in an 2N:2S square planar geometry.
1
To 
quantitatively evaluate the CD spectral changes, spectral deconvolutions of these data were 
performed to determine the energies and signs of the electronic transitions (Figure 3.5b). 
Whereas freshly prepared Ni-NCC displays signals with positive sign at 18 900, 22 170, and 26 
520 cm
-1
, the spectrum of the aged sample shows negative bands at similar energies (Table 3.1). 
These transitions shift to slightly lower energies %$~200 – 900 cm
-1
) with age. Bands 1 – 4 of 
freshly prepared Ni-NCC were previously assigned as d-d transitions
1
 and their energies should 
be very sensitive to changes in geometry about the Ni
II
 center.  The observation that the energies 
of these bands shift by < 900 cm
-1
 upon aging demonstrates that fresh and aged Ni-NCC have 
Figure 3.4. Change in CD spectrum at 19 200 cm-1 as Ni-NCC ages at pH 7.4, 8.4, and 
9.4 in 50 mM phosphate buffer. Data represents the average of two experiments, and error 
bars are the standard deviation of those two experiments. Data collected by A. Glass. 
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nearly identical coordination environments.  The major spectral perturbations are predominately 
due to changes in sign and intensity of CD features.  These minor changes in the d-d transition 
energies (Table 3.1) along with the virtually identical absorption spectra (Figure 3.5a) of fresh 
and aged Ni-NCC demonstrate that the geometry and ligands of the Ni
II
 center are unaltered and 




Figure 3. 5.  (a) Electronic absorption spectra of freshly prepared (red) and aged (blue) Ni-NCC in 50 mM 
phosphate buffer at pH 7.4.  (b) CD spectra of the same samples.  Individual Gaussian curves (…) and their sums     















Table 3.1. Transition energies derived from Gaussian deconvoluted CD spectra of freshly prepared and aged Ni-
NCC in phosphate buffer.  Bands having opposite sign in the fresh and aged spectra are shown in bold.   
Band 
Freshly Prepared Aged 
$# (M-1cm-1) Energy (cm-1) $#(M-1cm-1) Energy (cm-1) 
1 -0.1 14200 a a 
2 -0.21 16270 0.04 16000 
3 0.22 18900 -0.1 18000 
4 0.64 22170 -0.78 21600 
5 -0.44 23900 0.7 22000 
6 0.71 26520 -1.3 24800 
7 1.1 28475 1.22 28450 
aThe low signal-to-noise ratio between 11 000 and 14 000 cm-1 precludes reliable deconvolution 
within this spectral window. 
 
3.2.3. Magnetic circular dichroism 
!
To investigate whether a paramagnetic, tetrahedral intermediate is formed, magnetic CD 
(MCD) experiments were performed. Previous MCD experiments have shown that the primary 
Ni-NCC species in borate buffer at pH 10 is largely diamagnetic, although a minor paramagnetic 
(S=1) species was present.1 Here, MCD experiments performed on a freshly prepared Ni-NCC 
sample demonstrated that the species initially present in phosphate buffer is also primarily 
diamagnetic; a minor paramagnetic component that accounts for less than 1% of the sample may 
reflect an intermediate state that does not accumulate (Figure 3.6). After aging, these 
temperature-dependent signals are no longer observed. Therefore, it can be concluded that aged 
Ni-NCC contains neither appreciable amounts of S = 1 NiII or S = 1/2 NiIII centers.   These data 
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collectively show that both fresh and aged Ni-NCC contain diamagnetic NiII centers in square 
planar geometries with nearly identical coordination spheres; the differences in spectral features 
and in reactivity between the freshly prepared and aged samples led to further investigation of 
















Figure 3.6. Low-temperature MCD spectra collected for freshly prepared Ni-NCC and aged 





3.2.4. Electrochemistry and reactivity of Ni-NCC 
 Previous electrochemical experiments have shown that Ni-NCC in borate buffer at pH 
9.3 has a midpoint potential of 0.72 V (vs. Ag/AgCl).1   When attempts to measure the midpoint 
potential of Ni-NCC in phosphate buffer at the same pH were made, the complex prepared in 
phosphate buffer did not exhibit a measurable potential; however, when the same sample was 
aged for 24 hours, the midpoint potential was comparable to that of the sample in borate buffer 
(0.71 V vs. Ag/Ag+).  Previous studies have shown that square planar geometries, for example 
peptide mimics of Ni-SOD, coordinate cyanide in an axial position, as determined by IR of the 
bound cyanide.42 Similarly, IR experiments have demonstrated that Ni-NCC in borate buffer is 
capable of coordinating CN- in the axial position, as a shift in the &(C'N) vibration occurs.  The 
IR spectrum of Ni-NCC freshly prepared in phosphate buffer did not exhibit a peak 
corresponding to coordinated cyanide; however, addition of cyanide after aging the sample 
overnight generated the expected peak for the coordinated state (Table 3.2).  These data lend 
support to a slow structural rearrangement that occurs over the course of hours, resulting in a 
structure that allows for the interaction of a fifth ligand with the Ni-NCC complex.   
Table 3.2.  IR data for cyanide coordinated to nickel. 





Ni-NCC + CN- borate 2109 
Ni-NCC + CN- 
phosphate (fresh) 
N/A 





3.2.5. Deuterium exchange 
 The flip in sign of CD signals suggests the structural change that allows for ligand 
binding may be due to chiral inversion.  Because of this possibility, NCC was transmetallated 
with Ni-IMAC resin in buffers prepared in D2O to determine if deuterium would be incorporated 
into the peptide at any non-exchangeable site. After back-exchanging the Ni-NCC into 1:1 
water/methanol to preserve the integrity of the complex but remove any exchangeable deuterium 
atoms, ESI-MS demonstrated incorporation of deuterium into two non-exchangeable positions 
(392.98 vs. 394.99). ESI-MS of the same reaction performed in H2O showed no difference in m/z 
over 24 hours. Because Ni-GCC shows a similar inversion of CD signals with time, but lacks 
chirality in the first position, Ni-GCC was also examined for deuterium exchange.  Ni-GCC 
exhibited incorporation of deuterium into one non-exchangeable position, suggesting that the 
chirality of Asn in the first position and only one of the Cys is affected. This information was 
used to predict the possible location(s) of the incorporated deuterium atom(s).  
 
3.2.6. Characterization of peptides containing D amino acids 
!
 The LDL-Ni-NCC, LLD-Ni-NCC, and DLD-Ni-NCC complexes were generated and each 
analyzed using absorption and CD spectroscopies and ESI-MS.  All of the complexes exhibit the 
same mass profile (m/z=392.98) in ESI-MS, suggesting that each forms 1:1 complexes with the 
metal. To determine the chirality of the final, stable Ni-NCC arrangement, CD spectra of each D-
containing peptide were compared to the data collected for the aged (>40 days) Ni-NCC sample 
in phosphate buffer. The DLD-Ni-NCC spectrum overlaid with the aged Ni-NCC spectrum shows 
parallel features (Figure 3.7).  These data indicate chiral inversion occurs at the first and third 











Whereas the spectral features of DLD-Ni-NCC do not shift or lose intensity with time, the 
CD spectrum of LLD-Ni-NCC evolves over time to look like that of DLD-Ni-NCC (Figures 3.8 
and 3.9).  In contrast, the CD spectrum of aged LDL-Ni-NCC looks like the mirror image of that 
of DLD-Ni-NCC. When the freshly prepared peptides were reacted with cyanide, only DLD-Ni-
NCC was able to immediately coordinate cyanide in the axial position, providing further 








Figure 3.7.  CD spectra of Ni-NCC aged in phosphate 
buffer (black) vs. DLD-Ni-NCC (purple). 
Figure 3.8. CD aging progression of various chiral versions of the Ni-NCC complex. 










3.2.7. DFT-Optimized Models and Computed Energies 
Computations were performed on models of Ni-NCC to explore the structural and 
energetic changes associated with chiral inversion of the different amino acid residues in the 
tripeptide-NiII complex.  These results are summarized in Table 3.3. In the optimized structure of 
LLL-Ni-NCC, the nickel(II) ion is bound in a near-square planar geometry (Figure 3.10). The 
coordination of the terminal amine, internal amide, and sulfur of Cys2 form two five-membered 
chelate rings that share a common edge. The sulfur of Cys3 coordinates trans to the amide 
nitrogen, which requires that the peptide wrap around the nickel center, thereby blocking one 
coordination site perpendicular to the square plane. The other open coordination site is partially 
blocked by the Asn side chain. These results suggest that the metal center may be sterically 
occluded in the LLL-peptide complex, explaining the lack of CN- coordination observed in the 
freshly prepared samples described above.  
The energies of Ni-NCC models with the chirality of different amino acids inverted show 
that inversion of Asn1 leads to a model (DLL-Ni-NCC) that is isoenergetic to that of LLL-Ni-
NCC.  In addition, the models in which Cys2 is inverted, LDL- and DDL-Ni-NCC, have an 
Figure 3.9.  Change in CD signal at 19 200 cm-1 as Ni-NCC ages. (Generated by A. Glass). 
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energetic destabilization of ~5 kcal/mol when compared to LLL-Ni-NCC.  In contrast, when Cys3 
is inverted, as in LLD- and DLD-Ni-NCC, an energetic stabilization of ~11 kcal/mol is predicted.  
Investigation into the role of solvation on the total energy of the conformers shows that although 
DLD-Ni-NCC does have an overall stabilization with respect to LLL-Ni-NCC in solvation energy, 
the relief of steric strain of the loop containing Cys3 has a more pronounced effect on the total 
energy.  These results for DLD-Ni-NCC agree with the experimental data described above (Figure 
3.6). The inversion from LLL-Ni-NCC to DLD-Ni-NCC opens one face of the NiII ion to interact 
with exogenous ligands, consistent with the observation that aged Ni-NCC binds CN-. 
 
 
Table 3.3. Bond lengths (Å) and relative energies (kcal/mol) of DFT-optimized models of NiII-NCC with amino 














Ni-Namine 1.976 1.972 1.974 1.982 1.979 1.990 
Ni-Namide 1.890 1.856 1.867 1.866 1.866 1.887 
Ni-Scys2 2.222 2.184 2.165 2.179 2.164 2.196 
Ni-Scys3 2.161 2.199 2.199 2.221 2.199 2.238 
Relative 
Energy 













3.2.8. TD-DFT computations 
TD-DFT computations were performed to determine if the structural differences between 
LLL-Ni-NCC and DLD-Ni-NCC can account for the experimentally observed red-shift in the 
NiIId-d transition energies upon aging of Ni-NCC.  Because Ni-S bond lengths are frequently 
overestimated in DFT geometry-optimized models, it is expected that the predicted electronic 
transition energies for both Ni-NCC models will be computed at lower energy than 
experimentally observed. Nonetheless, this known shortcoming in DFT-computed Ni-S bond 
lengths43 will not hinder the analysis performed here, as the focus is on reproducing the relative 
shift in NiII d-d transitions between LLL-Ni-NCC and DLD-Ni-NCC. For an S = 0, d8 metal ion in 
a square planar geometry, four d-d transitions are expected from excitation from each of the four 
doubly-occupied d orbitals to the unoccupied dx2-y2 orbital. The computed energies of these 
Figure 3.10. Energy-minimized structures of LLL-, DLL-, and DLD-Ni-NCC.  The only hydrogen atoms shown 
are those attached to the C! of the residues. Views perpendicular to the square plane (a) and in the plane (b) are 
shown.  (Figure generated by A. Glass) 
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transitions are shown in Table 3.4; corresponding spectra are shown in Figure 3.11. Relative to 
LLL-Ni-NCC, all calculated d-d transitions for DLD-Ni-NCC are red-shifted, consistent with the 
experimental observation. This shift in transition energies is directly related to the energy of the 
dx2-y2 orbital. In an idealized square planar geometry (e.g., D4h symmetry), the dx2-y2 orbital is the 
dominant (* orbital and is significantly destabilized relative to the remaining four d orbitals. As 
the geometry is perturbed from this limit, other d orbitals take on partial (* character. This leads 
to the dx2-y2 orbital being at a relatively lower energy and a red shift in d-d transitions. The 
nickel(II) coordination sphere in DLD-Ni-NCC is more distorted from square planar geometry 
than that of LLL-Ni-NCC, which gives rise to a smaller splitting between the NiII d orbitals 
(Figure 3.12) and thus red shifted d-d transitions. 
Table3. 4. TD-DFT computed d-d transition energies (cm-1) for Ni-NCC models. 
Band LLL DDL DLD 
1 14 500 15 500 12 400 
2 15 600 16 600 14 300 
3 17 000 17 300 15 600 

























Figure 3.11.TD-DFT predicted absorption spectra of LLL-Ni-NCC (bottom) and 
DLD-Ni-NCC (top). NiIId-d transitions are marked with vertical lines. Figure 
generated by A. Glass. 
Figure 3.12. NiII d orbital energy level diagram for Ni-NCC models.  A structural model of DLD-Ni-NCC and 
the coordinate system used for all models (where the z-axis is pointing into the plane of the page) are shown to 
the right. Figure generated by A. Glass. 
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TD-DFT computations performed for DDL-Ni-NCC predict the three lower-energy d-d 
transitions to shift to higher-energy relative to LLL-Ni-NCC, which is inconsistent with 
experimental data. Taken together, both the total energies of the Ni-NCC models and the results 
of these TD-DFT computations are consistent with aged Ni-NCC corresponding to DLD-Ni-NCC, 
where the chirality of Asn1 and Cys3 have been inverted. 
 
3.2.9. Ni-SOD Activity 
 The Ni-SOD activity assay was performed in order to probe whether the structural 
rearrangement that Ni-NCC undergoes while aging has an effect on the ability of the complex to 
consume the toxic anion superoxide.  We previously showed that Ni-NCC behaves as a 
functional mimic of Ni-SOD, with an IC50 value of 41 µM.
1 
As computational analysis revealed, the final low-energy conformation, DLD-Ni-NCC, 
results in a more exposed Ni ion for solvent accessibility and reactivity with exogenous ligands.  
This is supported experimentally by the observed increase in SOD activity over time, as well as 
the lack of cyanide binding to Ni-NCC initially, prior to chiral inversion.1 Control experiments 
with NiSO4 verify SOD activity is only detected when Ni-NCC is present in solution.  SOD 
activity was measured at several time points while the Ni-NCC complex was aged. The activity 
change, as determined using the xanthine/xanthine oxidase assay, increased linearly with respect 
to time over the first several hours of the experiment. The initial activity was subtracted from the 
value measured for each aged sample, and these data were fit to a linear equation. Two replicates 
involving a total of 12 data points were analyzed to compare the change in SOD activity with the 
change in chirality of the aged Ni-NCC complex between 0 and 90 minutes. The data 
comparison shows a linear correlation between these two parameters with R2 values of 0.9242 
and 0.9543 (data not shown).  In addition, the functional data were compared to the intensity 
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changes in the CD spectra at the same time points during the aging process. A linear relationship 
between SOD activity and chiral inversion was observed (R2 = 0.9592), revealing a direct 
correlation between this structural change and SOD activity of the Ni-NCC complex (Figure 











Finally, after examining the control DLD complex immediately following formation, the 
IC50 value was determined to be 39 µM, which is the same as the aged LLL-Ni-NCC species, 




3.3.1. Structural rearrangement of Ni-NCC 
!
Metal incorporation into the described Ni-NCC complex is accomplished rapidly (within 
seconds) via metallation.1 The studies described here show that, following complex formation, 
Figure 3.13.  Change in SOD activity of Ni-NCC as a function of 
structural change over time, as measured by CD spectroscopy. 
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chiral inversion occurs over the course of hours to generate the DLD isoform, which correlates to 
SOD activity. The initial CD spectra acquired immediately following metal abstraction by the 
peptide differ among buffer systems but later converge to a common final state. The spectral 
differences observed between buffer systems are dramatic, whereas varying the pH (7 – 10) and 
sparging do not significantly impact the rate of aging.  Samples prepared in borate buffer reach 
the rearranged, final state much faster than samples prepared in phosphate buffer.  The Ni-NCC 
samples prepared in borate buffer also immediately coordinate cyanide in the axial position, 
while the Ni-NCC samples prepared in phosphate buffer must be aged overnight before cyanide 
coordination can be detected.  As mentioned above, these data lend support to a slower structural 
rearrangement that occurs over the course of hours-days, resulting in a structural state that allows 
for the interaction of a fifth ligand with the Ni-NCC complex. Similarly, Ni-NCC prepared in 
borate buffer has a midpoint potential that can be measured immediately using CV, whereas 
samples prepared in phosphate buffer must be aged overnight before any electrochemical signal 
is observed.  These studies demonstrate that there is a difference between the final and initial 
arrangements of Ni-NCC that are observed in different buffer systems. The initial state is likely 
the all L-coordinated square planar arrangement, which the DFT computations suggest would be 
sterically hindered from binding even small ligands (e.g. CN- and superoxide) due to occlusion 
by the asparagine side chain.  Furthermore, MCD experiments reveal that both the Ni-NCC 
species measured immediately after complexation and then after aging are predominantly S=0 
square planar.  
The differences in spectral features and in reactivity between the freshly prepared and 
aged samples of Ni-NCC prompted further investigation of the subtle changes in the Ni-NCC 
complex. Using spectroscopic and ESI-MS studies, including those involving deuterium 
exchange, it was proposed that a change in the chirality of specific residues within this metal-
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peptide complex occurs as a result of metal binding.  The incorporation of deuterium into non-
exchangeable positions further supports chiral rearrangement.   
Studies on the control peptides, GCC and those containing D-amino acids in various 
positions, helped elucidate the positions directly influenced by chiral inversion.  A Ni-GCC 
sample was examined in the same manner to evaluate the influence of chirality at the first alpha 
carbon position.  Although the spectra for these two complexes are not expected to be identical, a 
similar trend was observed for Ni-GCC in a similar time frame, suggesting that conversion 
occurs in the second and/or third positions. Recalling that NCC increased in mass by 2 amu 
during the deuterium exchange experiment, but GCC only increased by 1 amu and additionally 
taking into consideration that Gly is achiral, the data collectively indicate that only one of the 
Cys residues undergoes chiral inversion and that in NCC the first residue is also altered.  
To determine which cysteine residue undergoes chiral inversion, the D-containing peptide 
complexes LDL-Ni-NCC, LLD-Ni-NCC, and DLD-Ni-NCC were characterized. All of the 
complexes exhibit the expected mass profile when examined using ESI-MS, suggesting that the 
same moieties from each of these peptides participate to accomplish metal binding using the 
same geometry. In general, inversion of the chirality at the metal center leads to CD spectra that 
are complete mirror images of one another;44 however, changes in the CD spectra cannot be 
easily assigned to chiral inversions at individual positions in the peptide, and as such, the best 
indicator of the chirality of the final stable state is obtained through comparison to standards.  
By overlaying the spectra of the D-containing peptides with the aged Ni-NCC spectra, it 
is evident that the DLD-Ni-NCC spectrum displays the same features as the aged Ni-NCC 
spectrum.  These data further indicate chiral inversion occurs at the first and third position within 
Ni-NCC to generate the DLD-Ni-NCC complex. Moreover, it is obvious that the data for the aged 
all-L peptide does not correspond to inversion in the central position (Cys2), as the LDL peptide 
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yields a spectral mirror image of the aged complex. The changes observed in the aged LLL 
complex rather closely, but do not exactly, parallel those associated with D-Cys in the third 
position, as demonstrated by comparison to LLD-Ni-NCC. All of the possible permutations of 
chirality were tested with DFT, showing the DLD form to be thermodynamically favorable. Based 
on the DFT calculations, there is a very large difference in energy between the peptides 
containing an L or D amino acid in that third position, strongly corroborating that the DLD 
peptide-metal complex is highly favorable.   
The Ni-NCC complex was previously shown to mimic the Ni-SOD reaction in which a 
single electron is transferred through the metal center.1 Here we show that the SOD activity of 
Ni-NCC increases as the complex ages, and the activity is linearly and directly related to the 
structural rearrangement of the complex.  Although the structural rearrangement was unknown at 
the time of our previous report,1 the IC50 (data not shown) of the aged Ni-NCC sample is 
comparable with that value, indicating the original IC50 reflected a mostly chirally converted Ni-
NCC species. The direct measurement of the DLD complex also has a comparable IC50, indicating 
this is the species with SOD activity.  Chiral inversion has not been observed in the Ni-SOD 
protein or small peptide maquettes that have been used to probe the mechanism and structure of 
this protein. Although metal binding is accomplished with the same geometry and direct 
coordinating atoms in both cases, the connectivity among these atoms is not analogous. As the 
data and computations indicate, structural rearrangement of Ni-NCC from LLL to DLD promotes 
SOD activity by overcoming the steric hindrance that blocks ligand access to the axial position. 
Chiral inversion results in a substantially more favorable energy for the complex and a structure 
in which one face of the square planar NiII ion becomes more available for interaction with 





Here we have described the first metal-catalyzed site-specific chiral inversion of amino 
acids within a peptide.  While a previous study defined the ligands involved in metal 
coordination and the geometry by which the metal is bound,1 this study has elaborated the 
organization of the peptide in the complex and specifically shown that chiral inversion occurs at 
the first and third C! positions in the NCC sequence. An intramolecular hydrogen transfer 
occurs, likely through an intermediary carbon-centered radical, to generate the more 
thermodynamically stable DLD-Ni-NCC configuration. This stable isomer appears to be 
responsible for the majority of the SOD activity of Ni-NCC.   
!
3.5. References 
(1) Krause, M. E.; Glass, A. M.; Jackson, T. A.; Laurence, J. S. Inorg. Chem. 2010, 
49, 362-364. 
 
 (2) Szilagyi, R. K.; Bryngelson, P. A.; Maroney, M. J.; Hedman, B.; Hodgson, K. O.;  
 Solomon, E. I. J. Am. Chem. Soc. 2004, 126, 3018-3019. 
 
 (3) Wuerges, J.; Lee, J.-W.; Yim, Y.-I.; Yim, H.-S.; Kang, S.-O.; Carugo, K. D. Proc. 
 Natl. Acad. Sci. U.S.A. 2004, 101, 8569-8574. 
 
(4) Barondeau, D. P.; Kassmann, C. J.; Bruns, C. K.; Tainer, J. A.; Getzoff, E. D. 
Biochemistry 2004, 43, 8038-8047. 
 
 (5) Fiedler, A. T.; Brunold, T. C. Inorg. Chem. 2007, 46, 8511-8523. 
 
 (6) Fiedler, A. T.; Bryngelson, P. A.; Maroney, M. J.; Brunold, T. C. J. Am. Chem. 
 Soc. 2005, 127, 5449-5462. 
 
 (7) Shearer, J.; Dehestani, A.; Abanda, F. Inorg. Chem. 2008, 47, 2649-2660. 
 
 (8) Shearer, J.; Long, L. M. Inorg.Chem. 2006, 45, 2358-2360. 
 
 (9) Neupane, K. P.; Shearer, J. Inorg. Chem. 2006, 45, 10552-10566. 
 





 (11) Keyes, W. E.; Caputo, R. E.; Willett, R. D.; Legg, J. I. J. Am. Chem. Soc. 1976, 
 98, 6939-6945. 
 
 (12) Smith, G. G.; Khatib, A.; Reddy, G. S. J. Am. Chem. Soc. 1983, 105, 295-297. 
 
 (13) Stadtherr, L. G.; Angelici, R. J. Inorg. Chem. 1975, 14, 925-930. 
 
 (14) Pasini, A.; Casella, L. J. Inorg. Nucl. Chem. 1974, 36, 2133-2144. 
 
 (15) Jilek, A.; Kreil, G. Monatshefte fur Chemie 2008, 139, 1-5. 
 
 (16) Bobde, V.; Beri, S.; Rawale, S.; Satyanarayana, C. V. V.; Durani, S. Tetrahedron
 1995, 51, 3077-3086. 
 
 (17) Kreil, G. Annu. Rev. Biochem. 1997, 66, 337-345. 
 
 (18) Heck, S. et al. Science 1994, 266, 1065-1068. 
 
 (19) Nakagawa, S. H.; Hua, Q.-x.; Hu, S.-Q.; Jia, W.; Wang, S.; Katsoyannis, P. G.; 
 Weiss, M. A.  J. Biol. Chem. 2006, 281, 22386-22396. 
 
 (20) Jilek, A.; Molay, C.; Tippelt, C.; Grassi, J.; Mignogna, G.; M!llegger, J.; Sander,  
 C.; Fehrer, C.; Barra, D.; Kreil, G. Proc. Natl. Acad. Sci. 2005, 102, 4235-. 
 
 (21) Bansal, P. S.; Torres, A. M.; Crossett, B.; Wong, K. K. Y.; Koh, J. M. S.; 
 Geraghty, D. P.; Vandenberg, J. I.; Kuchel, P. W. J. Biol. Chem. 2008, 283, 8969-
 8975. 
 
 (22) Fujii, N. Biol. Pharm. Bull. 2005, 28, 1585-1589. 
 
 (23) Fujii, N.; Satoh, K.; Harada, K.; Ishibashi, Y. J. Biochem (Tokyo) 1994, 116, 663-
 669. 
 
 (24) Fujii, N.; Ishibashi, Y.; Satoh, K.; Fujino, M.; Harada, K. Biochim. Biophys. 
 Acta 1994, 1204, 157-163. 
 
 (25) Roher, A. E.; Lowenson, J. D.; Clarke, S.; Wolkow, C.; Want, R.; Cotter, R. J.; 
 Reardon, I. M.; Zurcher-Neely, H. A.; Heinrikson, R.; Ball, M. J.; Greenberg, B. 
 D. J. Biol. Chem. 1993, 268, 3072-3083. 
 
 (26) Kubo, T.; Nishimura, S.; Kumagae, Y.; Kaneko, I. J. Neurosci. Res. 2002, 70, 
 474-483. 
 
 (27) Nauser, T.; Sch"neich, C. J. Am. Chem. Soc. 2003, 125, 2042-2043. 
 
 (28) Mozziconacci, O.; Williams, T. D.; Kerwin, B. A.; Sch"neich, C. J. Phys. Chem. 




 (29) Neese, F.; Version 2.8 ed.; University of Bonn: 2009. 
 
 (30) Sinnecker, S. R., A.; Klamt, A.; Diedenhofen, M; Neese, F. J. Phys. Chem. A 
 2006, 110, 2235-2245. 
 
 (31) Becke, A. D. J. Chem. Phys. 1986, 84, 4524-4529. 
 
 (32) Perdew, J. P. Phys. Rev. B. 1986, 33, 8822-8824. 
 
 (33) Schaefer, A.; Horn, H.; Ahlrichs, R. J. Chem. Phys. 1992, 97, 2571-2577. 
 
 (34) Schaefer, A.; Huber, C.; Ahlrichs, R. J. Chem. Phys. 1994, 100, 5829-5835. 
 
 (35) Neese, F. J. Comput. Chem. 2003, 2003, 1740-1747. 
 
 (36) Becke, A. D. J. Chem. Phys. 1993, 98, 1372-1377. 
 
 (37) Becke, A. D. J. Chem. Phys. 1993, 98, 5648-5652. 
 
 (38) Lee, C.; Yang, W.; Parr, R. G. Phys. Rev. B. 1988, 37, 785-789. 
 
 (39) Crapo, J. D.; McCord, J. M.; Fridovich, I. Methods Enzymol. 1978, 53, 382-393. 
 
 (40) Tietze, D.; Breitzke, H.; Imhof, D.; Koeth, E.; Weston, J.; Buntkowsky, G. 
 Chem.--Eur. J. 2009, 15, 517-523. 
 
 (41) Bruschi, M.; De Gioia, L.; Zampella, G.; Reiher, M.; Fantucci, P.; Stein, M. J. 
 Biol. Inorg. Chem. 2004, 9, 873-884. 
  
 (42) Amouri, H.; Gruselle, M. Chirality and Entantiomers. In Chirality in Transition 





Chapter 4: Site-specific chiral inversion of NCC within longer peptides upon 
nickel incorporation 
 
The metal abstraction peptide (MAP) is a tripeptide with the sequence NCC that is 
capable of reacting with a metal ion to form a metal-peptide complex,1,2 in which the metal is 
coordinated in cis 2N:2S square planar geometry.  In NCC, the sulfur ligands derive from the 
cysteine side chains, one amino nitrogen ligand is from the N-terminus, and one amido nitrogen 
ligand is from the peptide backbone.1 Our previous studies on the tripeptide complex revealed 
that it is a functional mimic of nickel superoxide dismutase (Ni-SOD) and that site-specific chiral 
inversion of the first (Asn) and third (Cys) residues is vital to this observed activity.2 While metal 
is incorporated with the peptide composed of all L amino acids, over a period of hours to days, 
the LLL-NCC is converted to DLD-NCC.  This chiral inversion is critical for the superoxide 
dismutase activity, as conversion from the LLL to DLD form moves the asparagine side chain out 
of the way, allowing the substrate access to the unoccupied axial site of the metal center.  
Cyanide, a structural mimic of superoxide, was used to confirm that a fifth ligand can only 
coordinate to the metal center in the chirally inverted, or DLD, form. Additionally, 
electrochemical studies demonstrated that the expected midpoint potential is only observed after 
chiral inversion occurs, and SOD activity of the complexes increases with chiral inversion.2 
The structural change that occurs in the tripeptide complex is both site and structurally 
specific. When the tripeptide sequence is incorporated into a longer sequence, such as a 
pentapeptide, 8mer, or even a whole protein, metal is incorporated in a similar fashion, where the 
cysteinyl sulfur and backbone nitrogen ligands coordinate the metal.  Although the same 
nitrogens bind, the first nitrogen is embedded in a peptide bond, converting it to an amide, rather 
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than being the amino terminal nitrogen group.  As has been demonstrated in Ni-SOD and its 
maquettes, this change in binding moiety alters the redox potential and SOD activity.3 
Chiral inversion in proteins and peptides is rare; all naturally occurring, biosynthetic 
peptides and proteins that contain D amino acids are first generated entirely from L amino acids, 
and the inversion occurs as a post-translational modification. Racemases catalyze the site-
specific inversion of amino acids.4 D amino acids can form in mammalian proteins that are found 
in aged tissues, particularly racemization-prone aspartic acid residues.4,5 These spontaneous 
chiral inversions follow a mechanism involving cyclization and hydrolysis reactions, and the 
environment of the protein helps initiate and drive the conversion.5 Metal-amino acid chelates 
can undergo base-catalyzed racemization at the !-carbon, but conditions for inversion are harsh, 
requiring several hours at elevated temperature (>90 ˚C) and basic pH (>9).6-10 In contrast to 
these racemization mechanisms, complete conversion of L amino acids to D amino acids within 
proteins has been reported to proceed via a free radical reaction, where cysteine residues are 
involved in the single electron transfer event.11 In these unidirectional reactions, a cysteinyl 
radical is generated by UV light and subsequently abstracts hydrogen from a surrounding amino 
acid, leading to epimerization.11-14 
Interestingly, no chiral inversion has been observed in Ni-SOD15-17 or reported for peptide 
maquettes that contain the metal binding sequences that mimic the activity of Ni-SOD.3,18,19 In 
peptide mimics of Ni-SOD, it has been shown, however, that proline may undergo an 
isomerization reaction.  In native Ni-SOD, the Leu4-Pro5 bond is cis, but in some of the peptide 
mimics of the enzyme, it is trans.15,16,20,21 This may allow the carbonyl group within this bond to 
act as a fifth ligand and force the substrate to approach from the opposite side compared to the 
native enzyme.  This may explain why His1 is not necessary for catalysis in some of the 
maquettes;20 however, the issue is not resolved because studies on a forced cis-maquette exhibit 
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similar SOD activity to the trans form, suggesting proline isomerization is not likely influential 
in the activity of these sytems.21 
While the accessibility of the active site to substrate certainly impacts activity, Pro 
isomerization does not provide a point of direct comparison of the inner sphere effects on Ni 
chemistry.  The difference in amine/amide coordination versus bis-amide coordination in peptide 
sequences impacts the reactivity of the metal center.  Shearer and coworkers have performed 
studies on maquettes of Ni-SOD, which binds nickel(II) utilizing the N-terminus, a backbone 
nitrogen, and two cysteine side chains.  In these studies, where the maquette was acetylated to 
generate a bis-amide (versus not acetylated, with mixed amine/amide coordination), the redox 
potential and SOD activity of the complex changed.3 Studies on bis-amide vs amine/amide 
coordination in the maquette system suggest a difference in behavior of NCC (mixed 
amine/amide) and NCC within a longer sequence (bis-amide) may occur due to a similar factor.  
If the electronic properties vary slightly, the electron transfer reaction that is required for chiral 
inversion may also be impacted.  Converting the amine/amide to bis-amide coordination versus 
may not only impact SOD activity, but also chiral inversion, potentially altering the position or 
timescale of metal incorporation.  Here we compare the differences in reactivity of the NCC 
tripeptide alone versus NCC embedded in a longer sequence, with respect to chiral inversion and 
superoxide dismutase activity, to investigate the influence of bis-amide 2N:2S coordination 




4.1.1. Generation of metal-peptide complexes:  The peptides GGNCC, GGGCC, GNNCC, and 
GNGCC, as well as GGNCC with D-cysteine in the fifth position (XXLLD-GGNCC), GGNCC 
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with D-asparagine in the third position and D-cysteine (XXDLD-GGNCC) in the fifth position, and 
GGNCC with D-cysteine in the fourth position (XXLDL-GGNCC) were purchased from Genscript 
Corporation (Piscatway, NJ, USA).  The longer sequences GGGCCGGK and GGNCCGGK, 
where the sequence is in the middle of a peptide sequence rather than at a terminus, were also 
purchased.  Nickel-pentapeptide complexes were generated in either 50 mM potassium 
phosphate at pH 7.4 or in 50 mM sodium borate at pH 10 by adding one equivalent of NiSO4, 
while 8mer peptide-complexes were generated by incubation with nickel-charged immobilized 
metal affinity chromatography resin, as previously described.1,2 
 
4.1.2. Expression and purification of Ni-PRL-1: Ni-PRL was expressed and purified as described 
previously.22,23 Briefly, the gene for PRL-1 encoded in a pET-30 Xa/LIC expression vector was 
transformed into BL21(DE3)E. coli cells and grown at 37 °C in minimal media supplemented 
with trace metals in an orbital shaker at 250 rpm. Expression was induced with 1 mM IPTG at an 
OD600 of 0.6 to 0.8 and harvested by centrifugation after 3 hours.  Cells were lysed with a French 
pressure cell and centrifuged for 1 hour at 21,000 x g.  The soluble protein was purified using Ni-
IMAC chromatography, upon which metal was incorporated into the NCC tripeptide sequence.  
Protein was eluted with imidazole, the His tag was cleaved with Factor Xa, and a size exclusion 
chromatography step was performed to obtain the pure nickel-bound protein. Protein 
concentration was determined from the absorbance at 280 nm (#280= 19,420 L mol-
1 cm-1).  
 
4.1.3. CD and absorption studies:  Ni-peptide samples were placed in a cuvette with a 1-cm path 
length and scanned from 800-300 nm using both absorption and CD spectroscopy. Samples were 
scanned immediately after generation and then subsequently monitored at various time points.  
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Background scans of buffer alone were subtracted from each scan.  Spectra for Ni-PRL-1 were 
also collected immediately after purification.  Absorption studies were performed on an Agilent 
8453 UV/Visible spectrophotometer.  Circular dichroism analysis was performed on a J-815 
(Jasco Corporation) spectrapolorimeter.   
 
4.1.4. Deconvolution of CD and absorption data:  Deconvolution of CD and absorption data was 
performed using Igor Pro (Wavemetrics).  Iterative Gaussian deconvolutions were performed 
with a constant peak width of 1650 cm-1.  Absorption band energies were kept within 10% of the 
corresponding CD bands due to the broad nature of the absorption spectrum. 
 
4.1.5. ESI-MS:  Samples of Ni-GGGCC, Ni-GGNCC, Ni-GNNCC, and Ni-GNGCC were diluted 
100x in a 1:1 mixture of methanol/water and analyzed on an LCT Premier (Waters Corporation) 
operating in negative ion mode, as described previously.1,2 
 
4.1.6. Electrochemistry: Electrochemical data were collected as previously described.1 3-mL 
samples of 3 mM Ni-GGNCC and 3 mM GGGCC were prepared in 50 mM potassium phosphate 
at pH 7.4.  After incorporation, pH was raised to 10 to observe more intense signal.  CV data 
were collected with a CH1812C Electrochemical Analyzer potentiostat (CH Instruments) with a 
three-electrode setup (platinum working electrode, Bioanalytical Systems, Inc.; Pt auxiliary 
electrode; Ag/AgCl reference electrode) in a glass CV cell.  Potential was applied from zero to 




4.1.7. Coordination of cyanide and IR analysis:  Samples of Ni-GGGCC and Ni-GGNCC were 
prepared at a concentration of 3 mM in 50 mM potassium phosphate at pH 7.4. One equivalent 
of potassium cyanide was added to each of the samples.  Samples were flash frozen and 
lyophilized.  IR analysis was performed to observe the cyanide peak in each sample. IR spectra 
were acquired from dry powder samples on a Perkin Elmer Spectrum 100 FT-IR spectrometer 
equipped with a universal ATR (Attenuated Total Reflection) sampling accessory.  The spectrum 
of solid potassium cyanide was used to compare the shift of &(C'N) vibration from the free to 
the nickel-coordinated state.  
 
4.1.8. Ni-SOD xanthine/xanthine oxidase coupled assay: Ni-SOD activity was determined as 
reported previously,1 except Ni-peptides were generated in situ using one equivalent of NiSO4.  
SOD activity of Ni-GGGCC, Ni-GGNCC, Ni-GNNCC, and Ni-GNGCC was determined using 
the standard xanthine/xanthine oxidase method developed by Crapo and coworkers.24 All 
reagents were generated in 50 mM potassium phosphate, 100 µM EDTA reaction buffer at pH 
7.8 except for Ni-NCC, which was generated in 50 mM potassium phosphate, pH 7.4.  In this 
assay, 600 µM cytochrome c from bovine heart (Sigma), 300 µM xanthine (Sigma) and enough 
xanthine oxidase from buttermilk (Sigma) to cause a change in absorbance at 550 nm of 0.02 – 
0.04 AU per minute were added to a final volume of 300 µL with reaction buffer.  The change in 
absorbance at 550 nm was monitored on a Cary 100 UV-Visible spectrophotometer (Varian).  
 
4.1.9. MCD: Samples containing 3 mM Ni-GGNCC were prepared in 50 mM phosphate at pH 
7.4.  An equal volume of glycerol was added, yielding a 50% glycerol solution containing 1.5 
mM Ni-GGNCC.  The sample was placed in an MCD cell and flash frozen.  Spectra were 
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collected by A. Glass on a J-815 (Jasco Corporation) interfaced with an Oxford Spectromag 
4000 at +7 and -7 Tesla, and the difference was found via subtraction in order to remove any CD 
signal.   Spectra were collected at 20, 8, and 4.5 K, and analyzed to identify any changes in the 
spectra that indicate paramagnetic character. The feasibility of correlating these low temperature 
data with the structure of Ni-NCC at room temperature is demonstrated by the lack of apparent 




4.2.1. Preparation and spectroscopic characterization of Ni-peptides and Ni-PRL-1 
!
The NCC tripeptide sequence was incorporated into a series of four pentapeptides 
(GGNCC, GGGCC, GNNCC, and GNGCC), two 8mers (GGGCCGGK and GGNCCGGK), and 
also characterized within the full-length phosphatase in which it was discovered (PRL-1). As 
previously reported,1,2 metal incorporation in the appropriate geometry occurs via metal transfer 
from a weaker chelating moiety.  While immobilized metal affinity chromatography resin has 
been an ideal choice for obtaining pure compounds for examination following the metallation 
reaction, for studies requiring immediate spectroscopic analysis, a solution transfer is 
preferential.  Although NiCl2 fails to generate the desired complex, NiSO4 enables metal 
incorporation and provides the same spectral features without the need for a solid support.  The 
peptides were analyzed with CD spectroscopy to validate the ligands involved in the metal 
coordination.  While the spectral features were slightly different than those previously reported 
for the Ni-NCC tripeptide, this is to be expected, as the nitrogen ligand from the N-terminus in 
the tripeptide is replaced by an amide in the longer peptides.  The four pentapeptides have 
identical spectral profiles, with only differences in intensity (Figure 4.1).  Absorbance and CD 
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spectra were deconvoluted and features were compared to those of the tripeptide NCC (Figure 











Table 4.1.  Energies of spectral bands in Ni-GNNCC. 
Ni-GNNCC 
CD Absorption 
Energy (cm-1) $#  (M-1 cm-1) Energy (cm-1) #  (M-1 cm-1) 
16413 0.8 16 400 36 
19216 -3 19 100 90 
22500 1.74 23 600 250 
27 400 1.1 26800 220 
30 500 2.2 30500 600 
33 526 -3.25 32900 2200 
 
Figure 4.1.  CD spectra of Ni-pentapeptides in 50 mM phosphate pH 7.4.  Features are the 













Figure 4.2.  Deconvolution of Ni-GNNCC CD and absorption spectra. 
The tripeptide (NCC) sequence was also placed in the middle of the 8mers: 
GGGCCGGK and GGNCCGGK.  The spectral features are similar to that of the pentapeptides, 
showing that embedding NCC in a longer sequence does not further change the coordination, 
indicating the metal is bound in the same cis 2N:2S square planar arrangement as observed with 
NCC (Figure 4.3).  Differences in intensity are observed, likely due to differences in metal 
incorporation efficiency. ESI-MS operating in negative ion mode shows 1:1 ratio of peptide to 
metal (for Ni-GGNCC, m/z = 506.22, calculated = 506.02).  These data further indicate that the 
coordination is the same here as in the nickel tripeptide complex we reported previously (Figure 
4.4). The peptide GGNCHGGK was also used to show that the absence of one of the cysteine 
ligands provides different coordination. No CD signal was observed with this peptide after metal 
incorporation was attempted under the same conditions used for the other 8mers, suggesting this 
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histidine-containing peptide may be retained on the chelation resin (data not shown).  MS data 
indicate the metal did not insert into the modified sequence, suggesting the incorporation 
mechanism depends on the presence of the second Cys.  Mutation of the analogous Cys in PRL-1 
















Figure 4.4. Proposed coordination of Ni-GGNCC. 
Figure 4.3. CD of GGNCC, GGNCCGGK, and PRL-1, which contains the 
NCC sequence.  All samples were scanned 24 hours after metal 






 In the case of the Ni-NCC tripeptide complex, the nickel ion is primarily NiII;1 however, 
the change from amine/amide coordination that is present in the tripeptide to the bis-amide 
coordination that is present in the pentapeptide may stabilize a NiIII state and cause more of a 
NiII/III mixture to be present.  To test for the presence of NiIII, MCD data was collected on the Ni-
GGNCC sample.  MCD data show no temperature dependence of the spectra at field, which 
suggests that no paramagnetic component is present (data not shown). 
For the pentapeptide system, minor buffer-dependent differences in the spectral features 
are apparent at approximately 25 000 cm-1 (Figure 4.5), suggesting a possible interaction with 
one or both of the anionic buffer species with the complex. The choice of buffer has limited 
effect on reactivity of the complex after metal is incorporated.  Following the insertion reaction, 
no spectral changes occur over time except loss of intensity (Figure 4.6).  This lack of change 
over time suggests that chiral inversion either does not occur or it is concomitant with metal 









Figure 4.5. CD of Ni-GGNCC, showing buffer dependent features.  Ni-GGNCC in 50 mM 
potassium phosphate is shown in red, while Ni-GGNCC in 50 mM sodium borate is shown in 





Figure 4.6.  Aging does not change the spectral features of Ni-GGNCC within a given buffer system. 
 
 
4.2.2. Reactivity of pentapeptides:  SOD activity, coordination of fifth ligand, and 
electrochemistry 
!
With the NCC tripeptide, a measure of chiral inversion is the ability to bind of the 
complex to coordinate a fifth ligand, to have a measurable midpoint potential, and exhibit SOD 
activity.  To probe these three measures of reactivity of the pentapeptide immediately after 
generation, the xanthine/xanthine oxidase assay was performed, coordination of CN- was 
monitored with CD and IR, and electrochemical studies were performed using cyclic 
voltammetry (CV).  All of these studies were done on freshly generated samples to determine if 
activity, and therefore chiral inversion, occurs just after metal incorporation. 
The pentapeptides have reactivity similar to the aged NCC tripeptide (IC50 = 4.1 x 10
-5 
M),1,2 which corresponds to the activity of the chirally inverted form.  The longer peptides with 
an asparagine adjacent to the N-terminal side of the motif have slightly lower activity, (6.1 x 10-5 
M for GNNCC), while the longer peptides with a glycine adjacent to the N-terminal end of the 
















































Cyclic voltammetry was used to measure the midpoint potential of the pentapeptides.  
The GGGCC and GGNCC peptides have similar potentials (0.78 to 0.8 V vs Ag/AgCl at pH 10).  
These are slightly higher than those reported for the NCC tripeptide complex aged in phosphate 
buffer (0.71 mV vs Ag/AgCl).1 Interestingly, the pentapeptide signal can be measured 
immediately after generation, whereas the tripeptide generated in phosphate buffer does not have 
a measurable potential until it has aged.  The result suggests that chiral inversion may occur upon 
generation of the pentapeptide-metal complex.   
To determine if CN- has access to binding the metal, the pentapeptide complexes Ni-
GGNCC and Ni-GGGCC were generated, and CD was measured of each complex immediately 
before and after the addition of cyanide (Figure 4.7). The vibration of CN- is shifted to 
correspond to Ni-bound CN- (Table 4.2), as was observed previously with the tripeptide 
complex, suggesting that CN- is able to coordinate to the nickel-pentapeptide complex 
immediately after generation.  This suggests axial access is available immediately and structural 
rearrangement occurs concomitant with metal incorporation.   
Table 4.2. Coordination of CN- to different nickel species, showing that CN- coordinates to the pentapeptide 
immediately after generation, whereas with the tripeptide, chiral inversion must occur before a fifth ligand can bind.  
NCC and GGNCC samples were examined in phosphate at pH 7.4. 
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Ni-NCC + CN- 
(fresh)2 
N/A 
Ni-NCC + CN- 
(aged—chirally inverted)2 
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4.2.3. Characterization of Ni-pentapeptide complexes synthesized to contain D amino acids 
In the NCC tripeptide, chiral inversion occurs at the first and third positions, where nickel 
incorporated into LLL-NCC converts it to the DLD-NCC isoform over the course of hours. The 
inversion of the asparagine C! reorients its side chain away from the space above the plane, 
allowing coordination of a fifth ligand or substrate and thereby promoting activity.2 Based on the 
SOD activity of and CN- binding by the Ni-pentapeptide complexes immediately after 
generation, we hypothesized that chiral inversion within the NCC sequence is accelerated by the 
bis-amide coordination compared to the amine/amide complex. In order to further support the 
occurrence of chiral inversion in the pentapeptide and validate the proposed position(s), the 
pentapeptide XXDLD-GGNCC was examined and the nickel complex was generated.  CD spectra 
of the D-containing sequence were collected and compared to data from the all L isoform (Figure 
4.8).  Interestingly, the XXDLD- and XXLLL-GGNCC nickel complexes have spectra that are 
nearly mirror images of one another (Figure 4.8).  This indicates that the positions that undergo 
chiral inversion are not the same in the amine/amide and bis-amide complexes.  Moreover, the 
xxDLD form cannot be responsible for SOD activity in the pentapeptide complex.  
Figure 4.7. CD spectra of GGNCC in 50 mM potassium phosphate buffer scanned immediately after 










The peptides XXLDL-GGNCC and XXLLD-GGNCC were metallated and compared to the 
all L form, as well (Figure 4.9). The spectra of the peptides with D-cysteine (XXLLD and XXDLD) 
are different from that observed with the all L form of GGNCC, further indicating the site of 
chiral inversion differs between the pentapeptides and the tripeptide.  Although the XXLDL-
GGNCC is not an exact match, with different intensity ratios of the peaks at 27 500 and 22 500 
























Figure 4.8.  Comparison of CD profiles of purchased all L and XXDLD-GGNCC.  The two complexes 





The sequence NCC is capable of coordinating nickel in a 2N:2S geometry, where the 
sulfur ligands come from the cysteine side chains, one amino nitrogen ligand from the N-
terminus, and one amido nitrogen ligand from the peptide backbone. While metal is incorporated 
with the peptide composed of all L amino acids, the LLL-NCC is converted to DLD-NCC within 
hours.  After this site-specific chiral inversion, the Ni-tripeptide complex is a functional mimic of 
the enzyme superoxide dismutase. This chiral inversion is critical for the superoxide dismutase 
activity, as conversion from the LLL to DLD form moves the asparagine side chain out of the way 
and allows the substrate to have access to the unoccupied axial site of the metal center.  
 The tripeptide sequence may also be incorporated into a longer sequence.  Here, we 
examined the coordination of nickel into the NCC sequence within a series of pentapeptides 
(GGNCC, GGGCC, GNNCC, and GNGCC).  ESI-MS confirms monomeric incorporation of 
nickel into each sequence, and MCD studies reveal that the nickel is a diamagnetic nickel(II) 
species, as is the case in the tripeptide.  The CD spectral features differ from those of the 
tripeptide, which is expected because the nitrogen ligand from the N-terminus in the tripeptide is 
converted to an amide in the pentapeptides.  These data together indicate that the ligating 
moieties are the same; the same two cysteinyl sulfur and backbone nitrogen ligands are utilized, 
but the extension at the N-terminus changes the nitrogen coordination from mixed amine/amide 
to bis-amide.  The similarity of the four pentapeptides, with and without asparagine present in 
position 3, confirms that the asparagine side chain is not directly involved in metal coordination 
and nitrogen ligation is due solely to the backbone amides.  As is the case in the tripeptide 
system, minor buffer-dependent differences in the spectral features are apparent at approximately 
25 000 cm-1.  This suggests a possible interaction with one or both of the buffer species with the 
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complex. The buffer, however, has limited effect on reactivity of the complex after metal is 
incorporated, as no changes occur over time except loss of intensity.  Axial coordination of 
square planar complexes has been reported to alter band intensities in some cases without 
altering the absorption spectrum.26 In the case of the tripeptide, chiral inversion is slower in the 
presence of phosphate buffer than in borate buffer, but no changes occur over time in either 
system with the pentapeptide. This lack of change over time suggests that chiral inversion either 
does not happen or it is associated with metal incorporation, such that a change in CD signal is 
not observed.   
The Ni-NCC tripeptide complex is not able to bind a fifth ligand, have a measurable 
redox potential, or exhibit SOD activity until site-specific chiral inversion has occurred.  In 
contrast, even immediately after generation, the pentapeptides containing the NCC sequence 
exhibit all of these features, suggesting conversion to an arrangement with open access to the 
axial position or that the asparagine is oriented differently than in LLL-Ni-NCC.  Interestingly, 
the longer peptides that have an additional asparagine on the N-terminal side of the NCC 
sequence (GNGCC and GNNCC) have slightly lower activity, suggesting the presence of this 
side chain may slightly impair accessibility to the metal center and therefore reactivity.  
 In the tripeptide, LLL-NCC converts to the DLD-NCC isoform over the course of hours. 
The inversion of the asparagine’s C! reorients its side chain away from the space above the 
plane, allowing coordination of a fifth ligand or substrate, thereby promoting activity.2 Based on 
the reactivity of the Ni-pentapeptide complexes immediately after generation, it was 
hypothesized that chiral inversion within the NCC sequence happens quickly, upon metal 
incorporation. In the pentapeptides, XXDLD and what starts as XXLLL-GGNCC, nickel complexes 
! !
! 102!
have spectra that closely mirror one another, indicating that the XXDLD is not the isoform 
necessary for SOD activity of the pentapeptide complex.   
Because the complex formed from XXLLL-GGNCC closely resembles the mirror image of 
XXDLD, this led to the conclusion that inversion is likely occurring at the central cysteine position 
in the pentapeptides, generating XXLDL-GGNCC. This parallels the tripeptide, where DLD-NCC 
and LDL-NCC have CD spectra that are exact mirror images of one another. The XXLDL-GGNCC 
control was found not to be an exact match to the complex generated from XXLLL-GGNCC, as 
the ratios of the peak intensities at 27 500 and 22 500 cm-1 differ.  This similarity suggests Cys4 
indeed undergoes an inversion to the D form.  
 Pentapeptides that contain an inverted Cys5 have primarily negative features, with a 
positive feature at 18 500 cm-1, while peptides with an inverted Cys4 are the mirror image of this.  
This suggests that both cysteines do not invert and that only the cysteine at position 4 undergoes 
racemization.  The inversion of Asn3 has only a minor impact on the profile, as the spectra of 
XXDLD and XXLLD are highly similar.  Our previous work showed that DLD- and LLD-NCC have 
only minor spectral differences as well. It is likely that chiral inversion occurs at Cys4, but 
inversion at Asn3 may also occur, because the complex generated from the all L form also 
closely resembles the mirror image of the XXLLD form.  Thus, it can be deduced that either 
inversion in one position to XXLDL or in two positions to XXDDL occurs.  The peptide XXDDL was 
not examined, and it is possible that either or both chiral species form.  Regardless, the data 
indicate that GGNCC undergoes chiral inversion and at a different position than in the tripeptide.  
DFT calculations, chiral chromatography, or perhaps the characterization of additional peptides 
will be necessary to confirm the possible inversion of Asn3.   
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 The extension of the sequence from NCC to GGNCC causes several inherent differences 
in the two peptides.  First, the N-terminal amine that participates in binding in the tripeptide is an 
amide in the pentapeptide.  Second, the addition of extra residues can change the dynamics of the 
peptide and access to the metal center.  Either of these may be responsible for the chiral 
inversion occurring at a different position.  Inversion of the central cysteine in XXNCC allows 
access to the open axial site, as does inversion of the first and third positions in NCC. In the 
pentapeptide, the central Cys would then extend above the plane rather than below the plane as it 
does in the tripeptide.  This is a possibility, because the inversion in chirality appears to occur on 
the very rapid timescale of metal incorporation.  This, however, would suggest a difference in the 
mechanism of chiral inversion between the amine/amide and bis-amide systems.   
 The differences in bis-amide versus amine/amide coordination may alter both the rate of 
inversion and the difference in position at which chiral inversion occurs.  Studies on peptide 
maquettes of Ni-SOD have shown that the difference in amine/amide coordination versus bis-
amide coordination in peptide sequences can change the reactivity of the metal center, with 
respect to both redox potential and SOD activity.3 We confirm this by the changes observed in 
the redox potential for the bis-amide GGNCC (0.8 V vs Ag/AgCl) versus the mixed amine/amide 
NCC (0.72 V vs Ag/AgCl).  These studies comparing bis-amide and amine/amide coordination 
in other systems suggests the difference in behavior of NCC (mixed amine/amide) and XXNCC 
(bis-amide) may be due to a similar factor.  The bis-amide species likely facilitates faster chiral 
inversion and in a different position, on the timescale of metal incorporation, compared to the 
mixed amine/amide species. Further understanding of the differences between these two systems 
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Chapter 5.  Conclusions 
!
 The metal abstraction peptide (MAP) is a metal-binding tripeptide, described here with 
the sequence asparagine-cysteine-cysteine (NCC). The MAP was discovered serendipitously 
through IMAC purification of a phosphatase studied in the Laurence lab.  Phosphatase of 
regenerating liver (PRL-1) is a protein tyrosine phosphatase, falling into a class of proteins that 
do not bind metal.  Purification of this protein with nickel immobilized metal affinity 
chromatography (IMAC) resulted in elution of a protein with a reddish-brown color that could 
not be removed even after extensive dialysis with EDTA, with extensive heating of the protein, 
or through denaturation with 7 M guanidine-HCl.  ICP-MS verified that nickel was present, 
suggesting the presence of a high affinity metal binding site.  Tryptic digests indicated metal 
binding occurred near the C-terminus of the protein, and the use of site-directed mutagenesis and 
control peptides confirmed that the metal-binding sequence involved the three contiguous 
residues asparagine-cysteine-cysteine (NCC).  
The unique, high affinity binding of metal within MAP and its versatility to be easily 
encoded into proteins of interest leads to the possibility of many potential biotechnological and 
pharmaceutical applications, but in order to utilize this sequence as a metal-binding tag, it is 
important to understand the structure and reactivity of this novel system.  In order to accomplish 
this, extensive characterization of the nickel-bound form of the tag was performed.  Studies on 
the nickel-bound form of the tripeptide, Ni-NCC, reveal that the peptide binds NiII with a 2N:2S, 
square planar geometry. One of the novelties of this system, however, is the method of 
incorporation.  Metal incorporation into the desired geometry is accomplished by incubation with 
a weakly chelated nickel ion, where metal is transferred from the weak chelator to the peptide to 
generate a metal-tripeptide complex.  This reaction, termed transmetallation, is necessary for 
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generation of the desired 2N:2S, square planar NiII complex; the simple addition of metal in the 
absence of a chelator fails to provide the desired complex, providing an extrinsic method of 
selectivity.   
After characterizing the structure of Ni-NCC, similarities to the active site of the enzyme 
nickel superoxide dismutase (Ni-SOD) were realized, and closer comparison revealed that Ni-
NCC is a structural mimic of this enzyme. Ni-NCC and Ni-SOD both have 2N:2S coordination, 
utilizing a backbone amide, the N-terminal amine, and two cysteine side chains as ligands. 
Additionally, Ni-NCC acts as a functional mimic of Ni-SOD, catalyzing the breakdown of 
superoxide. While peptide mimics of Ni-SOD have been explored in the past, the MAP complex 
differs in that it is not derived from the sequence of the parent enzyme yet acts as a functional 
mimic of the enzyme.  While Ni-NCC is much less efficient than Ni-SOD, it shows activity and 
maintains a redox potential in the appropriate range to disproportionate superoxide. Unlike Ni-
SOD, however, and unlike any metal-peptide complex known, Ni-NCC undergoes a chiral 
rearrangement over time under ambient conditions.  Changes in the sign of the CD signal over 
time suggested the possibility of site-specific chiral inversion, and mass spectrometry and studies 
on peptides synthesized to contain D amino acids indicate chiral inversion occurs at two of the 
alpha carbon atoms in the tripeptide, leading to a DLD-NCC complex. This chiral inversion is 
unique, and to our knowledge, this is the first example of site-specific chiral inversion of amino 
acids that depends on metal binding. 
Because of the potential applications of the MAP tag and its use as part of longer 
peptide/protein sequences, understanding the behavior of this sequence in the context of a longer 
protein is important.  Additionally, understanding the peptide as part of a larger structure aids in 
the understanding of the primary coordination and the impact changes in this coordination can 
cause.   While NCC embedded in longer sequences utilizes the same ligands as the tripeptide 
! !
! 108!
itself, the extension of the sequence changes the nitrogen from an amine ligand due to N-terminal 
coordination to an amide.  This forces the two nitrogen ligands to both be amides, leading to a 
bis-amide 2N:2S coordination of the metal. The reactivity of NCC embedded in a longer 
sequence is similar to that of Ni-NCC.  The redox potential is altered somewhat, as expected 
when changing from mixed amine/amide to bis-amide coordination, but it is still appropriate to 
perform superoxide disproportionation.  While the CD profile of the nickel-tripeptide complex 
inverts slowly over time, no change is observed for the pentapeptide; however, the immediate 
ability of the pentapeptide to have the same reactivity as the tripeptide suggests it is already 
inverted in some form, allowing access to an axial, substrate binding position on the nickel 
center.  This suggests that in the case of the pentapeptide, chiral inversion occurs upon metal 
incorporation.  Interestingly, through the use of control D-containing peptides, it was observed 
that chiral inversion occurs in a different position; in GGNCC, Cys4 inverts to a D-chirality. 
It is proposed that the bis-amide coordination of the pentapeptide changes the electron 
flow within the complex and causes the chiral inversion to occur in a different position.  With the 
inversion of the central cysteine rather than the asparagine and terminal cysteine, the opposite 
face of the plane is likely open for reactivity.  The differences in this system are an excellent 
example of how a minor change in the structure, forcing amide coordination instead of amine, 
can change the properties of a nickel-coordination sphere enough to cause differences in the 
reactivity, which in this case, then causes further, more significant structural differences.  
 
5.1. Novelty of the metal abstraction peptide   
!
 Though proteins with cysteine residues have been reported to bind metal,1-3 the geometry 
and chemistry of the Ni-NCC motif is unique. Shortly after publication of our first paper in 
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Inorganic Chemistry describing the NCC sequence, moderate characterization of another CC 
containing peptide from the parent protein HspA was published.  As described above, HspA 
from Helicobacter pylori has a histidine- and cysteine-rich tail at its C terminus, which allows it 
to bind two nickel ions, one of which is specifically at a Cys-Cys sequence.2 Confirming our 
study, the authors propose a 2N:2S coordination, utilizing two cysteinyl side chains and two 
backbone amides.  Although their suggested structure is different than ours, less characterization 
has been performed and it is possible they have generated a similar metal-peptide structure.4 
Metallothionein is a small protein where approximately 30% of the residues in the sequence are 
cysteine.  This protein serves to coordinate soft, often toxic, metal ions.5 The sequences used to 
sequester metal in this protein include Cys-Cys, Cys-X-Cys, and Cys-X-Y-Cys, but many 
divalent cations can bind to this protein, and in a review paper, nickel coordination to this Cys-
Cys sequence was not described.6 No protein besides MAP that has been reported to bind nickel 
using adjacent cysteine residues has been shown to have any catalytic activity, and very little 
characterization of these complexes has been performed prior to our analysis of the MAP 
complex.  
 
5.2. Future directions 
!
Future directions of the nickel project are mechanistic in nature.  While site-specific 
chiral inversion has been observed in the first and third positions of the NCC tripeptide, the 
mechanism for this inversion remains to be determined.  Studies on the mechanism have already 
been initiated by our collaborators and will provide additional insight into the Ni-NCC system.  
Further, the difference in position of the chiral inversion in NCC in a longer sequence is very 
much of interest.  While it is likely that the difference in coordination between mixed 
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amine/amide in the tripeptide and bis-amide in the longer sequences drives the differences in 
reactivity with respect to chiral inversion, further characterization of this mechanism would be 
useful in understanding the overall reactivity of this system. Interestingly, in the case of the 
tripeptide, the inversion in borate occurs immediately, while in phosphate, it occurs slowly over 
the course of hours-days.  We suggested previously that borate might stabilize a NiIII species and 
cause the inversion to happen quickly; similarly, the presence of the bis-amide coordination may 
also stabilize NiIII, allowing quick chiral inversion to occur.  The difference in position is likely 
due to this coordination difference as well as the presence of additional residues on the N-
terminal end of the sequence. 
The work performed on the nickel complexes of these peptides has opened the door to 
additional studies on different metals with numerous biotechnological and medical applications.  
The MAP will be placed inline with therapeutic proteins or peptides that have the potential to be 
used as targeting agents.  Platinum, for example, may be used as an anti-cancer therapeutic.  Our 
work with nickel has determined the ligands important for metal binding, found the conditions 
that are useful for metal incorporation, as well as has probed basic principles of stability, 
structure, and reactivity.  While these will differ for each metal employed, basic principles and 
assays to monitor each of these variables have been established and will be useful in the 
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